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ABSTRACT 
 
HOMOLOGOUS RECOMBINATION-DIRECTED MECHANISMS OF 
ALTERNATIVE LENGTHENING OF TELOMERES 
 
Nam Woo Cho 
Roger A. Greenberg 
 
Telomere length maintenance is a requisite feature of cellular immortalization and 
a hallmark of human cancer. While most human cancers express telomerase activity, ∼10%-15% employ a recombination-dependent telomere maintenance pathway known as 
alternative lengthening of telomeres (ALT) that is characterized by multi-telomere 
clusters and associated promyelocytic leukemia protein bodies. However, the 
mechanisms that govern the lengthening process are poorly understood. Here, we show 
that a DNA double-strand break (DSB) response at ALT telomeres triggers long-range 
movement and clustering between chromosome termini, resulting in homology-directed 
telomere synthesis. Damaged telomeres initiate increased random surveillance of nuclear 
space before displaying rapid directional movement and association with recipient 
telomeres over micron-range distances. This phenomenon required Rad51 and the Hop2-
Mnd1 heterodimer, which are essential for homologous chromosome synapsis during 
meiosis. Recruitment of Rad51 and Hop2 to damaged telomeres was dependent on ATR 
and Chk1 signaling. These findings implicate a specialized homology searching 
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mechanism in ALT-dependent telomere maintenance and provide a molecular basis 
underlying the preference for recombination between nonsister telomeres during ALT. 
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CHAPTER 1. Introduction 
I. Homologous recombination safeguards genome integrity 
Homologous recombination (HR) is an evolutionarily conserved mechanism of 
DNA repair that is essential to genome integrity in meiotic and mitotic cells (Mazon et 
al., 2010; Moynahan and Jasin, 2010). In particular, this form of DNA repair as a 
response to double-strand breaks (DSBs) requires a highly coordinated process that 
culminates in an accurate search for and copying of a template DNA with sequence 
homology to the broken DNA. One of the critical early steps in this pathway is 
nucleolytic resection of DNA ends to generate 3’ single-stranded DNA (ssDNA) 
overhangs—this precludes ligation repair by the potentially more mutagenic non-
homologous end-joining (NHEJ) pathway (Symington, 2014). Instead, the ssDNA is 
rapidly bound by replication protein A (RPA), which is subsequently replaced by the 
Rad51 recombinase. Rad51-coated ssDNA nucleoprotein filament then initiates a search 
for homologous sequences (Qi et al., 2015). Successful capture of homology entails base 
pairing between invading single stranded DNA with the complementary strand of duplex 
DNA, forming a displacement loop (D-loop). Subsequent close association of the 
homologous strands (synapsis) and extension by DNA polymerases enables template-
directed DNA repair.  
HR-mediated DNA repair mechanisms are largely cell-cycle restricted to S and 
G2 phases in mitotic cells in eukaryotes when a sister chromosome is present and 
resection-promoting nucleases are more active (Aylon et al., 2004; Huertas et al., 2008; 
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Ira et al., 2004). HR between sister chromatids, rather than homologous chromosomes, is 
thought to be the vastly preferred mechanism of HR in mitotic cells (Johnson and Jasin, 
2000). Conversely, meiotic HR is not limited to sister chromatid recombination, but 
occurs extensively between sequences on homologous chromosomes (Neale and Keeney, 
2006).  Meiotic recombination involves a lineage-restricted, programmatic form of HR 
that is initiated by Spo11 induced DSBs and culminates in synapsis of distant 
homologous loci. This process requires Rad51 and Dmc1 as well as the heterodimeric 
Hop2-Mnd1 proteins, which promote Rad51- and Dmc1-dependent D-loop formation in 
vitro and are epistatic to these RecA homologs during meiosis in yeast and in mammalian 
organisms (Bishop, 1994; Chi et al., 2007; Petukhova et al., 2003; Pezza et al., 2007). 
Thus, 3-dimensional genome organization during physiologic meiotic recombination is 
intimately linked to the repair mechanisms that execute homology searches between non-
sister, homologous chromosomes.  
 
II. DNA damage responses at the telomere 
 A region of the genome that is particularly susceptible to DSB repair mechanisms 
is the telomere, a stretch of repetitive homologous DNA sequences (TTAGGG in 
vertebrates) that encase each eukaryotic chromosome termini. By virtue of their position 
at the end of linear chromosomes, telomeres are potentially recognized as DSBs in the 
absence of protective mechanisms such as T-loop formation and presence a multi-protein 
complex termed the Shelterin complex (de Lange, 2005; Griffith et al., 1999). Depletion 
of one or more of the components of the Shelterin complex predisposes the telomere to 
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specific pathways of DNA repair—NHEJ dependent telomere fusions occur in the 
absence of TRF2, for instance, and HR can proceed in the setting of POT1 and Ku70/80 
depletion (Sfeir and de Lange, 2012).  These Shelterin-deficient or -free telomeres elicit a 
robust DNA damage response, and are referred to as “dysfunctional” or “deprotected” 
telomeres.  
In addition, telomeres can shorten through a process known as the end replication 
problem. Due to the inability of the replication machinery to duplicate the region 
occupied by the RNA primer on the lagging strand, each cell cycle results in telomere 
shortening of about 50-150 base pairs (Martens et al., 2000). Cells that have gone through 
a sufficient number of divisions to reach a telomere length of 1-2 kilobases will undergo 
senescence. Those that can bypass senescence will most likely die from excessive 
damage responses at the telomere, especially during mitosis, in a phase known as crisis 
(Hayashi et al., 2015). Thus, telomeres represent a critical location in the genome at 
which DNA damage responses are normally appropriately suppressed in order to 
safeguard genome integrity and cellular viability.  
 
III. Mechanisms of telomere length maintenance 
Cells that continuously divide must avert cell death from telomere shortening and 
deprotection. The first mechanism is activation of a reverse transcriptase enzyme 
complex known as telomerase, and this occurs in 80-85% of all cancers as well as in 
normal germ and stem cells (Greider and Blackburn, 1985). The telomerase enzyme 
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complex uses a non-coding RNA template to processively add telomeric repeats to the 
ends of chromosomes. The second mechanism of telomere elongation, occurring in 10-
15% of human cancers, is termed the Alternative Lengthening of Telomeres (ALT). ALT 
is defined as telomere maintenance occurring in the absence of telomerase activity. In 
spite of the potential sequelae of aberrant DNA repair reactions at the telomere, cells that 
utilize ALT rely on template directed DNA recombination to maintain or lengthen their 
telomeres (Dunham et al., 2000). In cancers, telomerase reactivation and ALT each occur 
exclusively, even though each mechanism does not suppress the other given that ectopic 
expression of hTERT in ALT cells causes both length maintenance mechanisms to 
function concurrently (Cerone et al., 2001; Perrem et al., 2001). While anti-telomerase 
therapy has been explored, blocking telomerase may result in resistance by upregulation 
of ALT activity (Hu et al., 2012), highlighting the importance of understanding 
mechanisms in ALT to devise therapeutic approaches.  
 
IV. Hallmarks of ALT 
 ALT is defined as a mechanism of telomere length maintenance in the absence of 
telomerase activity. However, while this definition is one of exclusion, ALT cells 
typically demonstrate several hallmarks that positively identify them. The first is the 
presence of ALT-associated Promyelocytic leukemia Bodies (APBs), which contain 
telomeric DNA within the PML nuclear bodies, along with telomere associated proteins, 
DNA repair proteins and chromatin modifying proteins (Yeager et al., 1999).  Since DNA 
damage repair proteins can be found in PML bodies within non-ALT cells, the presence 
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of telomeric DNA is an exclusive finding in ALT-utilizing cells (Dellaire and Bazett-
Jones, 2004).   
 The presence of APBs correlates with telomere maintenance by ALT. Disruption 
of APBs by depletion of PML itself or components of the Mre11/Rad50/Nbs1 (MRN) 
complex suppresses telomere length maintenance in ALT cells (Jiang et al., 2005; Zhong 
et al., 2007). Furthermore, bromodeoxyuridine (BrdU) accumulation can occur within 
APBs in non-S phase cells, indicating that active DNA synthesis is occurring likely as a 
part of a DNA repair process as opposed to normal DNA replication (Nabetani et al., 
2004). Importantly, APBs are often strikingly large in size—they can reach sizes up to 
several microns—and can contain multiple telomeric material from different 
chromosomes as well as extrachromosomal telomeric fragments (Draskovic et al., 2009; 
Fasching et al., 2007; Komosa et al., 2015). This is critical for ALT-sustaining 
recombination reactions that require a donor and a recipient molecule for the formation of 
the D-loop. A high local concentration of DNA repair factors such as RPA32 and Rad51 
among a host of other factors likely facilitates recombination.  
 ALT has also been found to occur in cells lacking APBs (Cerone et al., 2005; 
Fasching et al., 2005; Marciniak et al., 2005). Interestingly, some of these cell lines 
display arrays of non-telomeric and telomeric amplificons arranged in tandem. This is 
analogous to ALT in Saccharomyces cerevisiae, where type I survivors show 
ampifications of both telomeric G-rich DNA and subtelomeric Y’ repeat elements, and 
type II survivors demonstrate amplifications of only the telomeric G-rich repeats. 
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Mechanisms governing these potential distinct pathways within ALT have not been 
investigated in detail.  
 The other hallmarks of ALT include long and heterogeneous telomere lengths, 
telomere sister chromatid exchanges (T-SCEs), and the presence of extrachromosomal 
telomeric repeats (ECTRs) such as double-stranded T-circles, largely single stranded c-
cicrles and linear DNA (Cesare and Griffith, 2004; Henson et al., 2009). These hallmarks 
are likely generated from the possible recombination reactions in ALT, which will be 
discussed next.   
 
V. Substrates of recombination of ALT telomeres 
 Due to the repetitive nature of telomeres, recombination at telomeres can 
theoretically occur with a variety of substrates and not necessitate a sister strand, which is 
normally the vastly preferred substrate for HR (Johnson and Jasin, 2000). These 
substrates, which are available even outside of S/G2 phases of the cell cycle, include 
telomeres from another chromosome, and ECTRs such as T-circles or C-circles. 
Interchromosomal telomeric recombination is evidenced in the initial study which 
characterized ALT, demonstrating interchromosomal copying of a telomere-integrated 
neomycin resistance tag (Dunham et al., 2000). Furthermore, interchromosomal telomeric 
bridges composed of telomeric sequences can be found in metaphase chromosome 
spreads of ALT cells (Draskovic et al., 2009).  While a rolling-circle amplification 
 
 
7 
mechanism such as those demonstrated in yeast is a possibility (Natarajan and 
McEachern, 2002), this has not yet been shown in human ALT cells.  
 Another possible substrate is the sister telomere in the S/G2 phases of the cell 
cycle. This activity is suggested by the presence of T-SCEs, which are post-replicative 
exchanges in G- or C-rich telomeric sequence resulting in a double signal at a particular 
chromosome end (Bailey et al., 2004; Londono-Vallejo et al., 2004). T-SCEs are 
generally elevated in ALT cells, although whether these exchange events actually lead to 
telomere elongation or merely represent increased recombination activity at ALT 
telomeres remains to be sorted out. Furthermore, exchange events can often occur at only 
one of the two sister chromatids, whereas a normal exchange between sister chromatids 
would result in double signals at both sister chromatids (Conomos et al., 2014). It is 
likely that these one-sided exchanges represent recombination with a non-sister substrate.  
 
VI. Current gap in knowledge and potential mechanisms of ALT recombination 
 A mechanistic understanding of how ALT telomeres recombine is needed. A 
plausible model follows a classical model for HR. In this model, the initial step of 
recombination involves generation of a 3’ overhang, which if at the end of the 
chromosome, is composed of the G-rich sequence. This overhang could be potentially 
generated by various nucleases such as Mre11, Exo1, CTIP and Dna2. Alternatively, they 
may be unmasked during the normal progression of replication through the telomere. 
This overhang should subsequently invade into homologous double-stranded substrate 
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telomere and form a D-loop. It is unclear, however, how this search for homology occurs. 
What are the factors that regulate the initial resection and homology search process?  
 Once the D-loop is formed, several reactions can proceed depending on the nature 
of the invading molecule. If both sides of the break contain homology to the intact 
substrate, repair could occur by formation of a double Holliday Junction leading to gene 
conversion (GC), or by synthesis-dependent strand annealing (SDSA). Gene conversion 
is the predominant outcome for breaks at the vast majority of DSBs in somatic cells. 
However, if the homology is one-sided or if the break is one-ended, repair can proceed by 
a process that may be similar to break-induced replication (BIR) as described in yeast 
(McEachern and Haber, 2006). This mechanism is particularly attractive to explain ALT 
recombination since the repair would proceed by continuous leading and lagging strand 
synthesis for greater than 100 kilobases, resulting in net elongation of the invading strand 
(Donnianni and Symington, 2013).  
While Rad51 is predicted to be important for the critical strand invasion process, 
it is notable that BIR in yeast can occur in a Rad51-dependent and –independent manner 
(Malkova et al., 1996). Furthermore, the two types of yeast survivors lacking telomerase 
can arise in the setting of Rad51 deletion (type II, telomeric amplification only) and in the 
setting of Rad50 deletion (type I, telomeric and subtelomeric amplification). It is unclear 
whether these types of pathways exist in human ALT cells and to what extent these 
potential mechanisms contribute to ALT telomere maintenance and survival.  
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Lastly, it is unknown what roles the major DNA polymerases play in telomeric 
DNA synthesis during ALT recombination. Pol32, a subunit of the delta polymerase 
complex, is important for yeast BIR (Lydeard et al., 2007) and its human ortholog PolD3 
has been reported to be important for BIR in mammalian cells (Costantino et al., 2014). 
Given these findings, it would be instructive to test the role of PolD3 in ALT telomere 
synthesis.  
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CHAPTER 2. Interchromosomal Homology Searches Drive Directional 
ALT Telomere Movement and Synapsis 
 
I. Introduction 
A subset of ALT telomeres coalesces into characteristic ALT-associated PML 
Body (APB) structures that display multiple telomeres from different chromosomes in 
association with PML (Draskovic et al., 2009; Jegou et al., 2009; Molenaar et al., 2003; 
Yeager et al., 1999). These multi-telomere bodies are thought to be sites of homology-
directed telomere synthesis (Nabetani et al., 2004). While the nature of the initiating 
stimulus for ALT recombination is unclear, one plausible mechanism is that DSB 
responses at a subset of ALT telomeres would represent a seminal event that initiates the 
search and capture of distant homologous DNA. Pairing and recombination between 
telomeres from different chromosomes during ALT would necessitate long range 
telomere movement.  
Damage dependent increases in local DNA mobility have been documented in 
both prokaryotes and eukaryotes, which may suggest that increased movement of broken 
chromosomes assists in repair of these loci (Aten et al., 2004; Chen et al., 2013; 
Dimitrova et al., 2008; Dion et al., 2012; Krawczyk et al., 2012; Mine-Hattab and 
Rothstein, 2012; Roukos et al., 2013). Interestingly, DNA damaging agents increase the 
prevalence of APBs in ALT cells, and a subset of ALT telomeres accumulates DNA 
repair proteins (Cesare et al., 2009; Fasching et al., 2007). Furthermore, while the 
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majority of telomeres in ALT-positive osteosarcoma U2OS cells display relatively slow 
mobility confined to a radius of less than 0.5µm, up to 15% of telomeres show unusually 
high mobility (Jegou et al., 2009; Molenaar et al., 2003). Yet, how increased mobility 
would facilitate efficient associations between damaged DNA and homologous genomic 
regions remains enigmatic, as are molecular events underlying such migration of DNA 
across the nucleoplasm lacking canonical structures of cellular transport such as 
microtubules. 
This section provides direct evidence that telomeric DSB responses drive inter-
telomere associations in the context of ALT telomeric chromatin. Strikingly, increased 
ALT telomere mobility culminated in rapid and directional movement over micron 
distances toward a recipient telomere, providing a real-time cellular visualization of 
homology search and synapsis in a mammalian cell nucleus. This process required the 
HR machinery including Rad51, which could be directly visualized in between 
recombining telomeres, representing a putative recombination intermediate. Moreover, 
these studies reveal that ALT cells commandeer proteins critical for meiotic 
recombination searching mechanisms, providing insights into this specialized form of 
HR-driven telomere maintenance. 
 
II. Telomere Double-Strand Breaks Increase the Hallmarks of ALT Recombination  
Telomeric chromatin is bound by a set of proteins that recognize double and 
single stranded repetitive telomere DNA, termed the Shelterin complex (Cesare and 
 
 
12 
Karlseder, 2012; Palm and de Lange, 2008). Fusion of the telomere repeat binding factor, 
TRF1, to the FokI nuclease catalytic domain targets DSBs specifically at telomeres in 
both telomerase positive and ALT cells, leading to a robust induction of DSB responses 
that extend hundreds of kilobases into subtelomeric chromatin (Tang et al., 2013). 
Further characterization of TRF1-FokI expression revealed a DSB response equivalent to 
approximately 1-2 Gy ionizing radiation in U2OS cells as assessed by western blot using 
antibodies to γH2AX, and phosphorylated-ATM (Figures 1A and B). Notably, Chk2 
phosphorylation was not increased to similar levels as phospho-ATM, consistent with 
prior reports that telomere damage signals are not efficiently transmitted to some ATM 
substrates (Cesare et al., 2013). Despite reduced transmission of ATM phosphorylation to 
Chk2, TRF1-FokI expression resulted in a nearly 2-fold increase in cells in the G2 phase 
of the cell cycle, consistent with the induction of a G2/M checkpoint (Figure 2A).  
Interestingly, TRF1-FokI expression resulted in up to 4-fold increases in average 
telomere foci size and reduced numbers of telomeres in each of 4 different ALT positive 
cell lines in comparison to cells expressing the nuclease inactive TRF1-FokI D450A 
mutant (Figures 1C, 1D and 2B). Telomere foci size increases did not occur in telomerase 
negative primary human IMR90 fibroblasts or 4 different telomerase positive cell lines.  
Telomere length difference between ALT and telomerase positive cells was not sufficient 
to explain foci size increases, as TRF1-FokI expression did not significantly increase 
telomere foci size in the telomerase positive HeLa 1.3 cells (Figure 1D), which have a 
mean telomere length comparable to ALT cell lines.  
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Telomeres within these larger foci in ALT cells contain chromosomally attached 
telomeres. This is supported by the observation that metaphase chromosome spreads from 
D450A and WT TRF1-FokI were not appreciably different with respect to the percentage 
of chromosome ends displaying telomeric signal, and by the presence of subtelomeric 
fluorescence in situ hybridization (FISH) signals or subtelomeric lac operator transgene 
repeats juxtaposing telomeres in interphase U2OS cells (Shanbhag et al., 2010) (Figures 
2C-E). Furthermore, expression of TRF1-FokI increased the percentage of multiple 
subtelomeric FISH signals accumulating at a telomere cluster (Figure 1E). These data are 
in agreement with previous reports that APB bodies contain chromosomally attached 
telomeres (Draskovic et al., 2009). However, they do not exclude the possibility that 
extra-chromosomal telomeric repeats (ECTRs), which increase in response to DNA 
damage, are also present in these large telomere bodies (Cesare and Griffith, 2004; 
Fasching et al., 2007).  
These findings suggest that DSB responses at ALT telomeric chromatin provide 
the initiating stimulus for telomere clustering. Consistent with this expectation, TRF1-
FokI expression induced multiple hallmarks of ALT recombination, including significant 
increases in telomeres associated with promyelocytic leukemia bodies (APBs) and 
telomere associated DNA synthesis as evidenced by incorporation of thymidine analog 5-
ethynyl-2’-deoxyuridine (edU) in non S-phase cells (Figures 3A-D and Figure 4A). 
Similar findings were not detectable in telomerase positive cells. Expression of TRF1-
FokI also increased c-circle formation, a specific indicator of ALT activity (Figures 4B-
E) (Henson et al., 2009). Moreover, TRF1-FokI expression increased telomere length 
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heterogeneity by Terminal Restriction Fragment Analysis in 3 different ALT cell lines 
(Figure 3E). The increased heterogeneity could result from a combination of factors, 
including telomere cutting by TRF1-FokI, as well as ALT recombination associated 
length changes and ECTR generation. These telomeres were sensitive to digestion by 
Bal-31, an exonuclease that degrades duplex DNA from both 3’ and 5’ ends, indicating 
that the longer telomere fragments observable following TRF1-FokI WT expression were 
not a consequence of telomere-telomere end joining (Figure 3F).  
 
III. Double-Strand Breaks Initiate Directional ALT Telomere Movement and 
Clustering  
The presence of intense ALT-like telomere clusters suggests that DSB responses 
initiate a homology search process, followed by synapsis and recombination between 
distant telomeres. To directly test this hypothesis, we visualized telomere movement 
using an inducible mCherryTRF1-FokI fused to a modified estradiol receptor and 
destabilization domain, which allowed small molecule induction by administration of 4-
hydroxytamoxifen and Shield1 ligand (Figure 5A). Following a 1-hour induction period, 
TRF1-FokI expressing cells were monitored over the following hour by capturing 
confocal z stacks of the entire nucleus every 2 minutes. Telomere foci were tracked in the 
z-projected plane, and a registration process (Thevenaz et al., 1998) assisted 
normalization for cellular movement. 
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Strikingly, telomeres in TRF1-FokI WT expressing cells demonstrated increased 
mobility and  an average of 7 telomere-telomere clustering events per hour between foci 
separated by up to 5µm (Figures 5B, C, E, F and Movie 1). Telomere clustering and 
movement were greatly diminished in the nuclease inactive D450A mutant or in cells 
expressing mCherry-TRF1 (Figures 5B-D and Movies 2 and 3). Importantly, less 
frequent instances of clustering were observed at mCherry-D450A and TRF1 containing 
telomeres, consistent with a previous report of an association of two telomeres in an 
unperturbed U2OS cell (Molenaar et al., 2003). TRF1-FokI induced DSBs at ALT 
telomeres greatly increase the frequency of telomere associations that normally occur in 
these cells.  
To determine if DSBs at other regions of the genome in ALT cells would 
demonstrate similar movement and clustering as those observed at telomeres, we 
monitored targeted and random DSB positions at non-telomeric locations. Fusion of FokI 
to the Lac repressor (mCherryLacIFokI) enables efficient visualization of DSB responses 
at lac operator repeat sequences integrated into chromosome 1p36 (Shanbhag et al., 
2010). mCherryLacIFokI DSBs did not display large increases in mobility at this locus in 
U2OS cells (Figures 6A and B).  GFP-53BP1 movement and clustering was also minimal 
at most ionizing radiation induced foci during time lapse imaging in U2OS cells (Figure 
6C). Conversely, telomeric DSBs moved coordinately with the sub-telomeric LacO locus 
in cells expressing both GFP-LacI and mCherryTRF1-FokI (Figure 6D). The lack of 
substantial DSB movement at non-telomeric regions of the genome is consistent with 
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reports that ALT cells display elevated recombination at telomeres, but not elsewhere in 
the genome (Bechter et al., 2003; Dunham et al., 2000). 
Importantly, the robust increase in ALT telomere movement allowed a 
quantitative analysis of this type of chromatin movement. Telomere tracks were subjected 
to a mean squared displacement (MSD) analysis, which plots the average squared 
displacements at each time interval, given by equation MSD = <(x(t+Δt)-x(t))2>, where x 
is the position of the focus and t is time. The MSD trajectories were then fitted to a single 
exponential time dependence diffusion model described by 𝑀𝑆𝐷 =   Γ𝑡!  where Γ is a 
generalized coefficient, and α is a time dependence coefficient which can be used to 
determine the type of motion. For α ~ 1, the particle is undergoing normal diffusion, and 
α < 1 represents sub-diffusion, also known as anomalous diffusion. Subdiffusive target 
searches in cells can result from molecular crowding of the nucleus and cytoplasm 
(Guigas and Weiss, 2008). Finally, α ≥ 2 represents an exponential dependence on time 
that indicates that the particle is moving in a directed manner, an example of which is 
active cellular transport.  
A comparison of averaged MSD trajectories for all telomeres in TRF1-FokI WT 
or D450A expressing U2OS cells revealed that α = 0.8 for WT and α = 0.7 for D450A, 
both characteristic of subdiffusive motion (Figure 5D). The Γ coefficient, which describes 
the magnitude of the behavior characterized by α, was greater for WT than for D450A, 
with values of 4.7x10-2µm2s-α and 3.3x10-2µm2s-α respectively. Calculation of time-
dependent diffusion coefficient 𝐷 𝑡 = 𝑀𝑆𝐷/𝑡 = Γ𝑡!!!  showed that the diffusion 
coefficient decreases linearly with time with a slope of α-1 when plotted on a log-log 
 
 
17 
scale, consistent with subdiffusive motion (Saxton, 2007). For D450A, D(t) at 15 minutes 
was 1.4x10-2µm2min-1, consistent with values for normal U2OS telomeres (Molenaar et 
al., 2003), and decreased to 0.9x10-2µm2min-1 at the end of the observation period (Figure 
6A). For WT, however, D(t) was consistently elevated at 2.6x10-2µm2min-1 and 1.9x10-
2µm2min-1 at 15 minutes and 60 minutes respectively (Figure 6E). These results indicate 
that damaged telomeres move faster and roam a larger nuclear territory.  
While all telomeres considered in sum demonstrated diffusive movement, it was 
readily apparent from imaging experiments that faster, “incoming” telomeres displayed a 
striking long-range directional movement prior to association with a comparatively slow-
moving “recipient” telomere (Figure 5B, E and Movie 1). For a quantitative analysis of 
this observation, mobility data from telomeres that merged into a recipient telomere was 
isolated. The terminal behavior of such telomeres was characterized by MSD analysis of 
the last 10 timepoints of each track, with the ultimate timepoint representing the merge 
event. The shape of the resulting MSD trajectory suggested an initial, increased diffusive 
movement for Δt of up to 10 minutes, followed by a transition to directed movement at 
large Δt (Figure 5G)  This change in behavior was clearly visualized on a log-log plot. 
The α coefficient for the initial portion of the clustering telomere trajectory was 0.9 
suggestive of diffusive motion, but between Δt of 12-18 minutes, there was a clear 
transition of α to ~ 2.3, indicative of directed movement (Figure 5H).  
The average displacement of telomeres during this directed phase was ~1.3µm 
with up to 4-5 µm observed for some tracks (Figure 5E, F). Following the clustering 
event, the merged telomere foci demonstrated reduced movement (Figure 3I), suggesting 
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the searching process that underlies directional movement had concluded. Interestingly, 
the less mobile, “recipient” telomere was associated with PML in 85% of clustering 
events (Figure 6F). This supports a model in which PML promotes clustering and 
recombination of telomeres within APBs (Chung et al., 2011; Draskovic et al., 2009).  
To further address whether the driving force behind ALT telomere movement is a 
DSB response, spontaneous telomere clustering events in mcherryTRF1 expressing 
VA13 cells were quantified with respect to colocalization of GFP-53BP1 as a marker of 
DSBs. Greater than 60% of clustering telomeres accumulated GFP-53BP1 prior to 
association, while 15% of all telomeres were associated with GFP-53BP1. This indicates 
that telomere movement and clustering is closely correlated with a local DNA damage 
response (Figure 6G, H).  
 
IV. Homologous Recombination Predominates at ALT Telomere DSBs 
The presence of random surveillance followed by directional DSB induced 
telomere movement could be a consequence of a homology search and capture between 
distant telomeres. Resection of telomeric ends would be a critical determinant of this 
pathway choice. RPA localization was assessed at telomeres in cells expressing TRF1-
FokI in ALT and telomerase positive cells. HeLa 1.3 did not significantly accumulate 
RPA at telomeres. Conversely, telomeres in both U2OS and VA13 cells were associated 
with RPA at baseline, which further increased in the presence of TRF1-FokI (Figures 7A, 
B). Furthermore, expression of TRF1-FokI in U2OS cells resulted in an increase in 
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single-stranded telomeres as assessed by electrophoresis and hybridization of telomeric 
probes under native conditions (Figure 7C). The increased ssDNA was largely derived 
from telomeric overhangs, since the native single stranded telomeric signal was reduced 
following treatment with ExoI ssDNA exonuclease (Figure 8A).  
Consistent with the observed increases in resection, homologous recombination 
proteins BRCA1 and Rad51 were present directly overlying 20-60% of telomeres in ALT 
cells and only 5-15% of telomeres in telomerase positive cells after TRF1-FokI DSB 
induction (Figures 7D and E). 53BP1 immunofluoresence juxtaposed BRCA1 in both 
ALT and telomerase positive cells, consistent with known differences of BRCA1 and 
53BP1 chromatin localization adjacent to DSBs (Figures 7D and 8B) (Chapman et al., 
2012; Tang et al., 2013).  
 
V. Rad51 and the HR Machinery Control Directional ALT Telomere Movement and 
Clustering 
These observations raise the possibility of homology directed telomere 
movement, analogous to the reported Rad51 dependency for DSB movement that occurs 
during homology searches in yeast (Dion et al., 2012; Kalocsay et al., 2009; Mine-Hattab 
and Rothstein, 2012; Oza et al., 2009). To test this hypothesis, TRF1-FokI induced 
telomere clustering was quantified following siRNA-targeted depletion of factors 
involved in either HR or NHEJ (Figure 9A and 10A). Knockdown of NBS1 and SMC5 
reduced telomere clustering in accord with their known involvement in ALT (Potts and 
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Yu, 2007; Wu et al., 2003; Zhong et al., 2007). Similar reductions were observed in cells 
following knockdown of either BRCA2 or Rad51, but not 53BP1 (Figure 9A) (Jiang et 
al., 2007). Interestingly, ALT telomere clustering was independent of BRCA1, consistent 
with the HR competency of cells that exhibit extensive resection as a consequence of 
53BP1 deficiency (Bouwman et al., 2010; Bunting et al., 2010). 
Rad51 molecules nucleate onto RPA-coated ssDNA forming a dynamic 
nucleoprotein filament which mediates the presynaptic search for homology (Renkawitz 
et al., 2014). Remarkably, expression of GFP-tagged Rad51 in VA13 cells allowed 
visualization of GFP-Rad51 filaments that originate specifically at telomeres and 
extended to distant telomeres (Figure 9B). Live cell imaging revealed that clustering 
could proceed by rapid shortening of the GFP-Rad51 filament with synchronous 
directional movement of the incoming telomere (Figures 9C and Movie 4). Of 35 
clustering events in cells in which a bridging filament formation was evident, 86% 
showed Rad51 localization. Rad51 filament could be directly visualized between 
recombining telomeres in approximately 46% of cases in which Rad51 was observable at 
telomeres (Figure 10B).  
MSD analysis revealed that Rad51 knockdown restricted telomere mobility as 
well as telomere clustering events that occur as a result of directed movement (Figures 
9D, E and Movies 5 and 6). Interestingly, telomere clustering was decreased by 
expression of an ATPase defective dominant negative mutant of Rad51, K133R, which 
inhibits HR in mouse cells and has been reported to lock Rad51 filaments into an 
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extended conformation that cannot transition to a compressed filament (Figure 10C) 
(Robertson et al., 2009; Stark et al., 2002).  
 
V. Hop2-Mnd1 Regulate ALT Telomere Movement and Recombination 
TRF1-FokI DSB-induced telomere recombination resembles certain aspects of 
recombination between homologous chromosomes during meiosis, which is also initiated 
by programmed DSBs and requires RecA homologs Rad51 and Dmc1. The Hop2-Mnd1 
heterodimer is necessary for Dmc1 and Rad51 dependent inter-homolog recombination in 
vivo during gametogenesis in yeast and in mice (Leu et al., 1998; Petukhova et al., 2003), 
and strongly stimulates Rad51 or Dmc1 dependent D-loop formation in vitro (Bugreev et 
al., 2014; Chi et al., 2007; Petukhova et al., 2005; Pezza et al., 2007). Moreover, Hop2-
Mnd1 or Dmc1 mutant yeast and mice display epistasis with respect to meiotic 
chromosome inter-homolog synapsis. Hop2-Mnd1 binds double stranded DNA and 
induces rapid condensation of large stretches of DNA in vitro, consistent with its 
requirement for homolog synapsis (Pezza et al., 2010). 
Hop2 protein was broadly expressed in all 16 different ALT cell lines and in 
telomerase positive cancer cell lines tested, with lower levels detected in primary human 
fibroblasts (Figures 11A and 12A-C). Endogenous Hop2 localized to approximately 10-
20% of TRF1-FokI damaged telomeres in VA13 cells and at lower levels in the absence 
of TRF1-FokI (Figure 12E, F). GFP-Hop2 foci localized adjacent to telomeres in a subset 
of ALT cells and foci formation was completely ablated by an M110P point mutant 
 
 
22 
within the Hop2 Leucine Zipper domain (Figures 12G, H). This domain is required for 
homolog pairing and recombination, with the Leucine Zipper also being necessary for 
Hop2 dependent D-loop formation in vitro (Pezza et al., 2006). Hop2 or Mnd1 
knockdown strongly reduced telomere clustering, mobility and directional movement to 
levels observed in D450A control cells (Figures 11B-D, 12D and Movie 7). Hop2-Mnd1 
depletion did not affect Rad51 localization to damaged telomeres (Figure 12I), in 
agreement with established roles for the heterodimer in meiotic inter-homolog pairing but 
not Rad51 or Dmc1 recruitment to Spo11 dependent DSBs (Petukhova et al., 2003).  
To determine if these results would be recapitulated with respect to telomere 
clustering and recombination in ALT cell lines that did not express TRF1-FokI, several 
different ALT lines were quantified for spontaneous APB formation following 
knockdown of Hop2 or Mnd1 with 5 different targeting siRNAs (Figures 11E, F and 
14A, B). Knockdown of either Hop2 or Mnd1 significantly reduced APB formation in 
each of these lines. The reduction in APBs could be fully rescued by stable expression of 
full length Hop2, which is resistant to a siRNA targeted to the 3’UTR (Figure 11G). To 
assess the impact of Hop2-Mnd1 on ALT telomere recombination, telomere chromatid 
exchanges were assessed by chromosome orientation-FISH (CO-FISH). Knockdown of 
Hop2 or Mnd1 reduced telomere chromatid exchanges by 50% or greater in ALT cells 
(Figures 11H, I and 14C). Collectively, these data reveal that the forces driving 
directional telomere movement are intimately connected to the mechanism of ALT 
telomere recombination based lengthening (Figure 13). 
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VII. Discussion 
The phenomenon of DSB movement has been described in prokaryotes, yeast and 
also in mammalian cells within distinct experimental contexts (Aten et al., 2004; 
Dimitrova et al., 2008; Dion et al., 2012; Kalocsay et al., 2009; Lesterlin et al., 2013; 
Mine-Hattab and Rothstein, 2012; Oza et al., 2009; Roukos et al., 2013). Telomeres 
appear to be a particularly predisposed genomic location to DNA damage induced 
mobility increases. Diffusive movement of damaged telomeres in telomerase positive 
cells has been reported in several independent studies (Chen et al., 2013; Dimitrova et al., 
2008). Notably, the NHEJ promoting factor 53BP1 was required for movement of 
deprotected mouse telomeres. However, TRF1-FokI induced directional ALT telomere 
mobility required HR factors and was independent of 53BP1, indicative of distinct 
mechanisms underlying telomere mobility in each case. Extensive end resection and more 
prominent accumulation of HR factors at damaged ALT telomeric chromatin likely 
contribute to these differences (Figure 13).  
Expression of TRF1-FokI enabled quantitative characterization of an 
unanticipated type of chromatin movement. Damaged ALT telomeres initially roamed a 
larger nuclear territory at greater velocities than D450A controls, but notably, these 
movements culminated in rapid and directional movements of up to 5µm to synapse with 
a more stationary recipient telomere. These displacements were also much larger in 
magnitude and occurred over a longer time period than those of stochastic unidirectional 
“jumps” that could be seen in interphase chromatin (Levi et al., 2005). We note, however, 
that pre-selection of clustering tracks in our analysis introduces a bias of describing only 
 
 
24 
highly mobile particles. The analysis of directionality was limited to clustering telomeres, 
and this analysis does not preclude the possibility that a proportion of non-clustering 
telomeres could move directionally.  
To our knowledge, directional ALT telomere movement provides the first 
example of real time visualization of homology searches and synapsis in mammalian 
cells. Given our data, we favor a model in which Rad51 nucleoprotein filaments 
interrogate surrounding nuclear space, leading to homology capture of a non-sister 
telomere and subsequent directional movement during synapsis (Figure 13). Interestingly, 
dynamic formation of long stretches of prokaryotic RecA coated filaments mediated 
rapid associations between DSBs and homologous genomic regions that are separated by 
1.3µm (Lesterlin et al., 2013), which are similar to the distances of directional phase 
movement we describe for ALT telomeres. The reported structure of ssDNA filaments in 
association with RecA reveals an extended conformation that is stretched to ~1.5 fold 
longer B-form DNA (Chen et al., 2008). Thus, it is predicted that 1.3µm of nuclear space 
connecting non-sister telomeres could theoretically require only ~2.5kb of Rad51 ssDNA 
filament for directional movement, which is well within the length possible for ALT 
telomeres. Furthermore, as vertebrate telomeres contain extensive regions of homology 
consisting of TTAGGG repeats, in effect every chromosome is a “homolog” with respect 
to telomere recombination. This feature of primary telomere sequence would be predicted 
to increase the probability of recombination between different chromosomes, enabling 
successful capturing of distant homology on timescales similar to those observed in much 
smaller genomes. It should also be noted that not all recombining telomeres displayed 
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Rad51 foci, consistent with the presence of Rad51 independent mechanisms of ALT in 
type II survivors of telomerase deficiency in yeast (Chen et al., 2001). 
Several obvious parallels exist between meiotic recombination and ALT. Both 
processes involve DSB responses to initiate recombination between homologous DNA 
sequences on non-sister chromatids. Hop2-Mnd1 uniquely contributes to chromosome 
pairing in meiotic recombination and ALT, but is not known to be important for sister 
chromatid recombination. Both constituents of this heterodimer are broadly expressed in 
ALT and telomerase positive cancers, yet appear to promote telomere recombination only 
in cells that use ALT. This may be a consequence of the known interaction of Hop2-
Mnd1 with Rad51, which did not efficiently nucleate damaged telomeres in telomerase 
positive cells. It is also plausible that other factors related to the specific chromatin 
environment in ALT cells, such as the absence of ATRX and the association between 
ALT and defective histone chaperone activity (Heaphy et al., 2011; Lovejoy et al., 2012; 
O'Sullivan et al., 2014; Schwartzentruber et al., 2012), may promote inter-telomere 
recombination. Mechanistic studies into this process are warranted, as is the extent to 
which ALT recapitulates known mechanisms of meiotic recombination.  
 
VIII. Experimental Procedures 
Cell culture 
Saos2 cells were grown in McCoy’s 5A medium (Invitrogen) with 15% fetal 
bovine serum and 1% penn/strep. DLD cells were grown in RPMI (Invitrogen) with 10% 
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calf serum and 1% penn/strep. All other cell lines were grown in DMEM (Invitrogen) 
with 10% calf serum and 1% pen/strep. VA13 cell line refers to WI-38 VA-13 subline 
2RA.  
 
Plasmids, primers and siRNAs 
Flag-TRF1-FokI fusion protein was cloned as previously described (Tang et al., 
2013) into the HFUW lentiviral vector. The coding sequence for mCherry, the modified 
estrogen receptor (ER) and destabilization domains (DD) were PCR amplified and cloned 
in frame into the N terminus of TRF1-FokI. Rad51 cDNA was cloned into pEGFP-C1. 
The N terminal GFP tagged Hop2 expression vector was generated by PCR amplification 
and ligation of Hop2 cDNA corresponding to isoform 2 (RefSeq NM_016556.3) from 
ProQuest HeLa cDNA Library (Invitrogen). Hop2 M110P mutant was generated by site-
directed mutagenesis.  
The following primers were used for qRT-PCR: GAPDH (IDT, PrimeTime assay 
Hs.PT.39a.22214836), Hop2/PSMC3IP (IDT, PrimeTime assay Hs.PT.56a.40246325.g), 
Mnd1 (IDT, PrimeTime assay Hs.PT.56a.1133039). 
The following siRNA sequences were used:  
Luciferase, 5’-GCCAUUCUAUCCUCUAGAGGAUG-3’ 
Control, (Qiagen Allstars) 
Rad51 #1, 5’-UGUAGCAUAUGCUCGAGCG-3’ 
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Rad51 #2, 5’-CCAGAUCUGUCAUACGCUA-3’ 
Rad51 #3, 5’-UGGAGGGCUGACAGCUUCC-3’ 
NBS1 (Santa Cruz) 
SMC5, 5’-GAAGCAAGAUGUUAUAGAA-3’ 
53BP1, 5’-UAUUACCGUCUCCUCGUUC-3’ 
CTIP, 5’-ACACACUCAUGGUGAUAAA-3’ 
BRCA1, 5’-AGAUAGUUCUACCAGUAAA-3’ 
BRCA2, 5’-GAAGAAUGCAGGUUUAAU-3’ 
Hop2 #1, 5’-GCAGCUACCAAUCAUGUGA-3’ 
Hop2 #2, 5’-AAGAGAAGAUGUACGGCAA-3’ 
Hop2 #3, 5’-UCUGCUUAAAGGUGAAAGUAGCAGG-3’ 
Hop2 #4, 5’-UAAAUGUUAACCUCAAGCUACUGCA-3’ 
Mnd1 #1, 5’-GCUAACAGAUGGACUGAUA-3’ 
 
All siRNAs were transfected at 20nM, except for double transfections where each siRNA 
concentration was at 10nM, using Lipofectamine RNAiMAX (Invitrogen).  
For Hop2 Mnd1 knockdown for APB quantification, knockdown was performed in series 
on day 1 and day 4 and cells were fixed on day 7.  
 
Antibodies 
The following antibodies were used: anti-53BP1 (rabbit, Novus), anti-BRCA1 D9 
(mouse, Santa Cruz), anti-γH2AX JBW301 (mouse, Millipore), anti-H2AX (rabbit, 
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Bethyl), anti-phosphoATM Ser-1981 (mouse, ECM Biosciences), anti-phosphoChk2 Thr-
68 (Rabbit, Cell Signaling), anti-Flag M2 (mouse, Sigma), anti-PML (mouse, Santa 
Cruz), anti-Rad51 H-92 (mouse, Santa Cruz), anti-Hop2/PSMC3IP (rabbit, ProteinTech 
11339-1-AP; rabbit, Novus NBP1-92301), anti-RPA2 (9H8, mouse, Novus).  
 
Transfections and lentiviral transductions 
Transient plasmid transfections were carried out with LipoD293 (Signagen), and siRNA 
transfections with Lipofectamine RNAiMax (Invitrogen) according to manufacturer’s 
instructions. Concentrated TRF1-FokI lentivirus with polybrene (8ug/ml) diluted in 
media was added to cells at a minimum titer resulting in greater than 90% expression at 
24 hours by immunofluorescence. Analyses were performed 16 hours after transfection of 
plasmids, and 48-72 hours after siRNA transfection. Analyses were performed 24 hours 
after transduction of cells with Flag-TRF1-FokI lentivirus.  
 
Western blot 
Cells were collected and lysed in RIPA buffer or for histone fractions, acid extracted. 
Proteins were resolved on a 4-12% bis-tris gel (Invitrogen). Transferred membranes were 
blocked in 5% milk and incubated with primary antibody overnight. For western blot 
following TRF1-FokI expression, cells were collected 24 hours after addition of 
lentivirus. Cells were collected 72 hours following siRNA transfections.  
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Immunofluorescence, IF-PNA FISH and subtelomeric FISH 
For anti-Hop2 immunofluorescence, permeabilized coverslips were blocked with 10% 
goat serum for 30 minutes at 37°C, followed by incubation with primary antibody for 16h 
at 37°C. Coverslips were washed and incubated with appropriate secondary antibody for 
20 minutes at 37°C, then mounted onto glass slides using Vectashield mounting medium 
with DAPI (Vector Labs).  
 
edU fluorescence assay 
16 hours after cells were transfected with mCherry-ER-DD-TRF1FokI, media was 
changed to contain 10µM (final) edU. Cells were pre-incubated for 2 hours then Shield1 
and 4-OHT were added to the media to induce TRF1FokI for 2 hours. Cells were fixed 
and edU was labeled with Alexa488 using Click-iT chemistry (Invitrogen).  
 
Pulsed field gel electrophoresis and in-gel hybridization 
Genomic DNA was purified using the Masterpure DNA Purification Kit (Epicentre) per 
manufacturer’s instructions. 15ug of purified DNA was digested using AluI and MboI, 
and resolved on a 1% PFGE agarose gel (Biorad) in 0.5X TBE buffer using the CHEF-
DRII system (Biorad) at 6V/cm; initial switch time 5, final switch time 5 for 10-16h. 
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Following electrophoresis, the gel was dried at 50ºC for 3h and processed for native or 
denaturing probe hybridization. For native hybridization, the dried gel was incubated 
with p32 end labeled (TTAGGG)6 oligo probe at 42º for 16h in Church buffer, washed 4 
times in 4X SSC and exposed onto a storage phosphor screen (GE Healthcare) and 
scanned using STORM 860 with ImageQuant (Molecular Dynamics). For denaturing 
hybridization, the gel was denatured in 0.5N NaOH/1.5M NaCl, neutralized and 
incubated with p32 end labeled (TTAGGG)6 oligo probe as above. 
 
Nuclease digestion of genomic DNA 
For Bal31 digestion, purified genomic DNA (5ug) was incubated with Bal31 (2 
units per reaction, TaKaRa/Clontech) in buffer provided by manufacturer for various 
timepoints at 30ºC, followed by inactivation in 20mM EDTA at 65ºC for 10 minutes. The 
Bal31 digested DNA was then purified by phenol-chloroform extraction and resolved by 
PFGE as above. For Exo1, purified genomic DNA (10ug) was incubated with Exo1 for 
16h at 37ºC, purified with phenol-chloroform extraction and resolved by PFGE. 
 
C-circle Assay 
Purified genomic DNA was digested using AluI and MboI (New England 
Biolabs). 15ng or 30ng of DNA was diluted to 10ul, then combined with 10ul of 0.2 
mg/ml BSA, 0.1% Tween, 1mM each dNTP without dCTP, 1x φ29 Buffer (NEB) and 
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7.5U φ29 DNA polymerase (NEB). Samples were incubated for 8 hours at 30°C then the 
polymerase was inactivated for 20 minutes at 65°C. Samples were diluted with 2x SSC to 
60ul, then dot-blotted onto Hybond N+ membrane (GE Healthcare). After UV 
crosslinking, the membrane was hybridized with p32 labeled (CCCTAA)6 oligo at 37°C 
in Church buffer for 16h. Membrane was exposed onto a storage phosphor screen (GE 
Healthcare) and scanned using STORM 860 with ImageQuant (Molecular Dynamics).  
 
Chromosome orientation FISH (CO-FISH) 
Telomeric CO-FISH can be used to assess the level of postreplicative exchanges 
involving a telomere and another TTAGGG repeat sequence, and has been described in 
detail previously(Bailey et al., 2004; Londono-Vallejo et al., 2004). Briefly, cells were 
incubated with BrdU/BrdC (7.5µM, 2.5µM respectively) for 21h (less than one cell 
cycle). Mitotic cells were collected after treatment with 0.1ug/ml colcemid for 90 
minutes. Subsequently, cells were incubated in 75 mM KCl and fixed on ice with fresh 
fixative (3:1 methanol / acetic acid). Fixed cells were dropped onto slides at 42ºC, and 
allowed to dry o/n. The slides were treated with 0.5mg/ml RNaseA for 15 minutes at 
37ºC, then with 0.5mg/ml Hoechst 33258 for 15 minutes at RT. Slides were exposed to 
365nm UV light for 30 minutes to introduce nicks in the BrdU/C incorporated replicated 
strands. The nicked strands were digested twice with 10U/ul ExonucleaseIII (Promega) in 
buffer supplied by manufacturer at RT for 10 minutes. Ethanol dried slides were stained 
with TelC-Cy3 and TelG-Alexa488 PNA probes (Panagene).  
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Live cell imaging 
Cells were transfected with mCherry-ER-DD-TRF1-FokI 16 hours prior to 
induction with 4-OHT and Shield1 ligand for 60 minutes. Confocal images were acquired 
under temperature controlled conditions calibrated to 37ºC, using a 100x 1.4 NA 
objective on an inverted fluorescence microscope (DM6000, Leica Microsystems) 
equipped with an automated XYZ stage (Ludl Electronic Products), a charge-coupled 
device camera (QuantEM 512SC, Photometrics), an X-LIGHT Confocal Imager (Crisel 
Electrooptical Systems), and a SPECTRA X Light Engine (Lumencor), controlled by 
Metamorph Software (MDS Analytical Technologies). Images were collected as z stacks 
at 0.6 µm intervals that covered the entire nucleus, at 2-minute intervals for a total of 60 
minutes. Images were processed using ImageJ (NIH). Each z stack was projected onto a 
single z plane for each timepoint, and then the t stack was registered using StackReg 
plugin in ImageJ to normalize for cell movement. Tracking of individual foci was 
performed using the TrackMate plugin for ImageJ (Perry N, Tinevez JY and Schindelin 
J). The Mean Square Displacement (MSD) values were calculated using MSD = 
<(x(t+Δt)-x(t))2>, where x is the position of the telomere and t is time in minutes. 
Resulting data were analyzed and visualized in MATLAB (MathWorks) using the class 
@msdanalyzer (written by JY Tinevez, Institute Pasteur). The error bars for each data 
point represent the weighted s.e.m. where weights are set to be the number of points 
averaged to generate the MSD value at the given delay.  
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The MSD trajectories were fitted to a single exponential diffusion model 
described by 𝑀𝑆𝐷 =   Γ𝑡!  where Γ  is a generalized coefficient, and α is a time 
dependence coefficient. The fitting was performed using least-squares fitting in 
GraphPad Prism.  
Calculation of the time dependent diffusion coefficient was performed by 
calculating 𝐷 𝑡 = 𝑀𝑆𝐷/𝑡 = Γ𝑡!!!  (Saxton, 2007).  For particles undergoing 
anomalous/subdiffusion, D(t) decreases linearly with time with a slope of α-1when 
plotted on a log-log scale. 
For analysis of clustering telomeres as in Figure 3G, H, telomere tracks were pre-
selected for those that displayed clustering during the course of imaging. Telomeres that 
clustered during the final 2/3 of the movie were selected to ensure enough datapoints for 
movement preceding the association event. Then, the last 10 time points for each of these 
tracks were used for analysis (last 10 points prior to the joining event). For the analysis of 
incoming and recipient telomeres vs. post merge as in Figure 3I, clustering events that 
occurred during the middle 1/3 of the movie were analyzed.  
 
Analysis of telomere foci size and clustering 
For measurements of telomeric foci size, ImageJ (NIH) was used to apply a 
constant threshold to images and subsequent binarization. Foci sizes were measured as 
square pixels for each telomeric focus within a nucleus and the average size was 
calculated for each nucleus analyzed. For analysis of clustering following siRNA 
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transfection, a cluster was defined as a telomeric focus equal to or greater than four-fold 
the area as based on the radius, compared to the average size of undamaged telomeres.  
 
Statistics 
Unpaired t tests were used to generate two-tailed p values. 
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CHAPTER 3. Regulation of ALT telomere recombination by the ATR-
Chk1 kinase pathway 
I. Introduction 
 A network of signaling pathways ensure proper coordination of the complex 
sequence of molecular reactions that are required for completion of DNA repair. Double-
strand breaks will activate ataxia-telangiectasia mutated (ATM) kinase. If the DSB is 
further resected to reveal single-stranded DNA onto which RPA rapidly binds, this 
structure recruits and activates ataxia-telangiectasia mutated and Rad3-related (ATR) 
kinase (Ball et al., 2005). Importantly, ATR is also activated during normal replication 
when ssDNA is exposed and ensures proper progression of the replication fork especially 
during periods of replication stress (Flynn and Zou, 2011). Downstream of ATM and 
ATR kinase activation, Chk2 and Chk1 kinases are phosphorylated respectively (Falck et 
al., 2001; Liu et al., 2000). Subsequent phosphorylation-mediated inhibition of 
Cdc25A/B/C phosphatases results in inhibition of cyclin-dependent kinases (CDKs), 
leading to cell cycle arrest. This temporary block allows sufficient time for completion of 
DNA repair.  
 The ATR-Chk1 pathway is critical for protection during replication stress both 
locally and globally. At the stalled replication fork, ATR stabilizes the structure of the 
fork and prevents collapse of the fork (Cobb et al., 2003; Lucca et al., 2004). In the 
absence of ATR, collapsed forks could degenerate into DSBs by structure-specific 
nucleases such as Mus81, posing a particular threat to cellular viability (Doe et al., 2002). 
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ATR also phosphorylates Chk1, which diffuses globally throughout the nucleus to 
suppress new origin firing (Shechter et al., 2004; Sorensen and Syljuasen, 2012). 
Inhibition of ATR or Chk1 results in deregulated origin firing and generation of DSBs 
globally from collapsed forks, leading to irreversible catastrophe and cell death (Buisson 
et al., 2015; Toledo et al., 2013).  
 It was recently shown that ALT activity is disrupted upon ATR inhibition and that 
ALT positive cells are selectively killed by ATR inhibition (Flynn et al., 2015). RPA 
coated ssDNA telomeres, characteristic of ALT cells, likely serves as a substrate to 
activate ATR. However, it is unclear how ATR would regulate ALT activity. One 
possibility is a direct effect of ATR-mediated phosphorylation on proteins mediating 
ALT recombination. Alternatively, ATR inhibition may exert its effects through 
disruption of replication at telomeres as well as the rest of the genome. In this section, I 
show that inhibition of ATR or Chk1 activities disrupt Rad51 and Hop2 localization to 
ALT telomeres, and that prevention of excessive replication origin firing and DSB 
generation partially alleviates this stress.  
 
II. Inhibition of ATR and Chk1 activity disrupts HR factor localization at ALT 
telomeres 
 To test if ATR or Chk1 activity contributes to ALT telomere recombination by 
altering recruitment of HR factors, ALT cells were treated with small molecule inhibitors 
of ATR or Chk1 kinases. VE-821, which inhibits ATR with an IC50 of 13nM in vitro, 
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and LY-2603618, which inhibits Chk1 with an IC50 of 7nM, strongly reduced Hop2 
localization to telomeres in VA13 cells (Figure 15A, C). Hop2 localization was reduced 
to less than 50% by 4 hours of treatment, and continued to decline until 24 hours of 
treatment (Figure 15 B, D). CHIR-124, another potent Chk1 inhibitor with an IC50 of 
0.3nM, reduced Hop2 colocalization with telomeres similarly to LY-2603618 in VA13 
cells (Figure 15F). Reduction of Hop2 at telomeres by ATRi was also apparent in 
GM847, another ALT cell line (Figure 15 E). Knockdown of ATR recapitulated the loss 
of Hop2 in VA13 cells, while knockdown of ATM only marginally affected Hop2 and 
knockdown of RNF168 significantly increased Hop2 localization to telomeres (Figure 
15G).  
 In order to test if localization of other HR factors is affected by ATR and Chk1 
inhibition, RPA and Rad51 were visualized at ALT telomeres by immunofluorescence. 
Interestingly, RPA32 foci maintained colocalization with telomeres even after treatment 
with VE-821 in VA13 cells (Figure 16A, B). U2OS cells expressing TRF1-FokI also 
largely retained RPA32 foci after treatment with VE-821 or LY-2603618 (Figure 16E). 
On the other hand, inhibition of ATR and Chk1 significantly reduced Rad51 recruitment 
to telomeres similarly to Hop2 (Figure 16C, D, F). These results show that ATR or Chk1 
inhibition, but not ATM or RNF168 inhibition, specifically perturb Rad51 and Hop2 
localization to ALT telomeres while RPA recruitment is unaffected.  
 
III. Inhibition of ATR and Chk1 results in genome-wide DNA fragmentation 
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 Since ATR inhibition results in replication fork breakage and DSB generation 
(Toledo et al., 2013), we tested whether telomeres in ATR or Chk1-inhibited ALT cells 
could be fragmented. Indeed, VA13 cells treated for 24h with VE-821 or LY-2603618 
revealed numerous nuclei with striking increase in fine telomere PNA signals suggestive 
of telomere DNA breakage (Figure 17A). The nature of the fine PNA signal is unlikely to 
be from generation of extrachromosomal C-circles, since their abundance is unchanged 
with ATRi or Chk1i (Figure 17B). In order to confirm that telomeric DNA is being 
fragmented, cells treated with VE-821 or CHIR-124 were embedded in agarose plugs and 
subjected to pulsed-field electrophoresis in the absence of liberation of DNA by 
enzymatic digestion (Saleh-Gohari et al., 2005). This method allows visualization of 
DNA fragments that would otherwise be trapped in or near the plug if they were still part 
of the intact chromosomal DNA. Treatment with VE-821 or CHIR-124 resulted in 
increases in telomere fragments that were most apparent at 24 hours (Figure 17C-E). To 
test if breakage was occurring exclusively at telomeres, fragmentation at non-telomeric 
locations was assessed using probes recognizing the Alu repeat sequence. This analysis 
revealed that ATRi- or Chk1i-induced breaks are not exclusive to telomeres (Figure 17C, 
D). In fact, breaks containing the Alu sequence increased more rapidly than those 
containing the telomeric sequence (Figure 17E).  
 Recent data suggests that generation of DSBs and single stranded DNA from 
ATRi and Chk1i occurs during S phase (Buisson et al., 2015; Toledo et al., 2013). To 
analyze the relationship between emergence of DNA breaks and cell cycle, SV40-
transformed ALT cell line derived from primary human fibroblasts, LM216JALT, was 
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treated with VE-821 or CHIR-124 and analyzed by flow cytometry for γH2Ax and 
propidium iodide (PI) signal (Figure 18A, B). With VE-821 treatment, the percentage of 
cells positive for γH2Ax doubles by 8 hours and there is a three-fold increase by 24 
hours. For CHIR-124, the percentage of γH2Ax-positive cells increases more rapidly. By 
4 hours, there is a four-fold increase and by 24 hours, there is a 10-fold increase in the 
percentage of cells that are γH2Ax positive. For both inhibitors, the rise in γH2Ax occurs 
mostly in S/G2 populations (Figure 18A, B).  
 To test whether this increase in γH2Ax was specific for ALT cells, LM216TTEL 
cells, which express telomerase and are ALT-negative, were analyzed also by flow 
cytometry after treatment with VE-821 and CHIR-124. The percentage of total γH2Ax 
positive LM216TTEL cells increased similarly to LM216JALT cells (Figure 18A, B). 
Interestingly, in LM216TTEL cells, the increase in γH2Ax occurred not only in S/G2 cells 
but also in G1 cells. This is unanticipated and the mechanism for generation of breaks in 
the G1 population requires further investigation. Regardless, it can be concluded that the 
phenotype of DNA fragmentation following ATR or Chk1 inhibition is not specific to the 
ALT status of cells.  
 
IV. Limiting replication-dependent fork breakage partially rescues the loss of 
Rad51 and Hop2 from ALT telomeres 
 Previous studies have reported that DNA fragmentation following ATR or Chk1 
inhibition can be suppressed by limiting  new origin firing by administration of a CDK-
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inhibitor roscovitine and by reducing processing of stalled replication forks by 
knockdown of Mus81 nuclease (Buisson et al., 2015; Toledo et al., 2013). Indeed, 
treatment of VA13 cells with roscovitine strikingly reduced ATRi and Chk1i-dependent 
DNA fragmentation assessed by southern blot (Figure 19A). The percentage of γH2Ax 
positive cells also decreased 10-fold by treatment with roscovitine (Figure 19B). One 
possibility is that generation of DNA fragments could divert factors such as Hop2 or 
Rad51 away from telomeres in a dilution manner since DSBs are prevalent throughout 
the nucleus. If so, reduction of DSBs by roscovitine treatment or Mus81 knockdown 
should allow Hop2 and Rad51 to return to telomeres. In VA13 cells, treatment with 
roscovitine or Mus81 knockdown by siRNA transfection partially rescued Rad51 and 
Hop2 localization to telomeres (Figure 19C-F). While roscovitine almost completely 
prevented DSB generation by ATRi or Chk1i, the magnitude of rescue of Rad51 or Hop2 
was only 30-50%. This strongly suggests that ATR and Chk1 inhibition works through 
additional mechanisms to suppress Rad51 or Hop2 localization to telomeres.  
 
V. Abrogation of Hop2 expression by CRISPR/Cas9 disrupts ALT activity 
 In order to test the effect of complete Hop2 loss from ALT cells, we utilized the 
CRISPR/Cas9 system to stop the expression of Hop2 in VA13 cells. Several guide RNAs 
targeting exon 1 of Hop2 were each transfected into VA13 cells along with Cas9 
expression, and resulting cell populations were analyzed by western blotting (Figure 
20A). The guide RNAs demonstrated varying levels of efficiency in terms of reduction in 
Hop2 expression. Interestingly, the guide sequence sgHop2-b resulted in an absence of 
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any detectable Hop2 expression by western. This was confirmed by the complete absence 
of Hop2 immunofluorescence signal in VA13 cells (Figure 20B). Cells selected for 
sgHop2-b expression (VA13 sgHop2) were then analyzed for ALT activity. Compared to 
the parental VA13 cells, sgHop2 cells demonstrated a 50% reduction in number of 
telomere PNA signals colocalizing with PML (APBs) (Figure 20C, D). Furthermore, 
clustering was reduced in sgHop2 cells as assessed by average telomere PNA FISH foci 
size (Figure 20E). BrdU incorporation occurring outside of S phase was also reduced, 
along with the frequency of telomere exchanges assessed by CO-FISH assay (Figure 20F, 
G). The reduction of ~50% in ALT activity is similar to the effect observed by Hop2 
knockdown using siRNA.  
 
VI. Discussion 
 One of the unique characteristics of ALT cells that distinguish them from 
telomerase positive cells or non-stem somatic cells is the persistent localization of RPA at 
telomeres (O'Sullivan et al., 2014). This substrate is likely recognized by ATR; however, 
the events occurring downstream of ATR activation in ALT cells is unclear. Here, we 
show that HR factor localization is significantly reduced upon ATR or Chk1 inhibition. 
Hop2 and Rad51 were rapidly removed from telomeres within 4 hours of treatment with 
ATR or Chk1 inhibitors, while knockdown of ATM or RNF168 did not have the same 
effect. Interestingly, RPA localization did not decrease following ATRi or Chk1i, 
suggesting that the effect of ATR or Chk1 inhibition on Hop2 and Rad51 localization is 
downstream of RPA loading onto telomeres.  
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ATR and Chk1 kinases possess an overwhelming number of phosphorylation 
substrates that coordinately serve to protect the genome in situations such as replication 
stress and fork stalling/collapse. In the absence of the kinases, one of the most striking 
phenotypes is the generation of DNA DSBs resulting from unregulated origin firing and 
resultant fork collapse. In ALT cells, ATR and Chk1 inhibition results in fragmentation 
of telomeric DNA as shown by the appearance of numerous fine telomere PNA FISH 
signals and by the increase in mobile DNA fragments during electrophoresis. However, 
this fragmentation is not specific to telomeres and occurs throughout the genome, 
resulting in large increases in percentage of γH2Ax positive cells. In agreement with 
previous reports, this breakage was reversed upon suppression of new origin firing with 
roscovitine or conversion of stalled forks into DSBs by Mus81. These findings strongly 
support a model in which the ATRi/Chk1i-induced fragments are generated during S and 
G2 phases of the cell cycle and are dependent on conversion of replication forks into 
DSBs.  
We tested the hypothesis that the generation of DNA DSBs upon ATR or Chk1 
inhibition contribute to the absence of Hop2 and Rad51 from ALT telomeres. However, 
while DSBs and γH2Ax were almost completely reduced, Rad51 and Hop2 localization 
to telomeres were only partially rescued. Furthermore, reduction of Rad51 and Hop2 
occur rapidly following addition of ATR or Chk1i (Figure 15B, D) whereas 
fragmentation is most apparent at 8-24hours of treatment (Figure 17C, D). These findings 
suggest that additional mechanisms, such as reduction of direct phosphorylation of Rad51 
and/or Hop2, could contribute to their loss from telomeres upon ATRi or Chk1i.  
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Lastly, additional experiments are needed to investigate how ATR and Chk1 
potentially function uniquely in ALT cells compared to non-ALT cells. When comparing 
ALT-positive LM216J cells to ALT-negative but telomerase positive LM216T cells, the 
levels of induction of γH2Ax were similar between the two cell lines. One possibility is 
that with limiting amounts of HR proteins in the nucleus, the generation of DSBs would 
dilutionally draw these factors away from ALT telomeres, causing dysfunction. Whether 
ATR or Chk1 inhibition would affect ALT telomeres uniquely in this way remains to be 
tested.  
 
VII. Experimental Procedures 
CRISPR/Cas9 Cell line generation 
 The following primers were used as guide RNA sequences.  
sgHop2-a: GCCGGACGTTGTAGTTGCTCG 
sgHop2-b: GCGGGAAAGGCGATGAGTAA 
sgHop2-c: GCGGGAGGTAACGGCGCCGT 
sgHop2-d: GAGTAGATTCACCCGTTGTC 
sgHop2-e: GACCCATGAGAGCCCGACAAC 
 To generate the cell lines, cells were first transduced with and selected for 
blasticidin resistance using lentivirus generated from lentiCas9-Blast plasmid (Sanjana et 
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al., 2014). Cells were then transduced with and selected for puromycin resistance using 
lentivirus generated from lentiGuide-Puro plasmids containing the guide RNA sequences 
targeting Hop2. Expression of Hop2 was assayed by Western blot 7 days after guide 
RNA transduction.  
 
Chemical reagents 
 VE-821 (Selleck Chemicals) was used at a final concentration of 5uM. CHIR-124 
(Selleck Chemicals) was used at a final concentration of 100mM. LY-2603618 (Selleck 
Chemicals) was used at a final concentration of 1uM. Roscovitine (Sigma) was used at a 
final concentration of 10uM.  
 
DNA Fragmentation Assay 
 1 million cells were collected by trypsinization and embedded in 1% low melting 
point agarose plugs. Plugs were digested overnight in proteinase K digestion buffer 
(100mM EDTA pH 8.0, 0.2% sodium deoxycholate, 1% sodium lauryl sarcosine, 1mg/ml 
proteinase K) at 50ͦC. After washing in TE, DNA in digested plugs was resolved on a 1% 
PFGE agarose gel (Biorad) in 0.5X TBE buffer using the CHEF-DRII system (Biorad) at 
6V/cm; initial switch time 5, final switch time 5 for 16h. Following electrophoresis, the 
gel was dried at 50ºC and processed for denaturing probe hybridization. The dried gel 
was denatured in 0.5N NaOH/1.5M NaCl, neutralized and incubated with p32 end 
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labeled (TTAGGG)6 oligo probe overnight. The washed gel was exposed onto a storage 
phosphor screen (GE Healthcare) and scanned using STORM 860 with ImageQuant 
(Molecular Dynamics).  
 
Flow cytometry 
 Cells were collected by trypsinization, washed in ice cold PBS and fixed in 70% 
ethanol. Permeabilized cells were stained with FITC-conjugated anti- γH2Ax antibody 
(Millipore) and with propidium iodide. Cells were analyzed on BD FACSCALIBUR and 
data was analyzed using FlowJo software.  
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Chapter 4. Conclusions and Future Directions 
 The scope of the present thesis was to investigate the mechanisms of telomere 
recombination in alternative lengthening of telomeres. Understanding the mechanisms 
driving ALT is of important therapeutic significance since all cancers rely on one of two 
telomere maintenance mechanisms. While numerous therapeutic approaches target 
telomerase in an effort to treat ~85% of cancers that overexpress the enzyme, there are no 
available treatments for ALT-utilizing cancers, partly due to lack of a mechanistic 
understanding of ALT recombination.  Major gaps in knowledge exist in terms of the 
initiating events leading to ALT, the nature of the substrates for recombination, the 
choice of recombination pathways, the composition of the recombination machinery and 
the mechanism for DNA synthesis during repair. The present thesis contributes to a 
model for ALT recombination that initiates from a DSB response-driven HR reaction. 
However, additional studies are required to further probe the linearity of this model by 
testing for other parallel recombination mechanisms that may coexist in ALT, and to 
understand how the actual DNA synthesis and elongation occurs to ensure survival of 
ALT cancers.  
 Generation of the TRF1-FokI system allowed coordinated induction of ALT 
activity and thus enabled a direct view of the initiating events during ALT telomere 
recombination. TRF1-FokI expression increased ALT activity, measured by levels of 
APB formation, C-circle generation, telomere heterogeneity and new DNA synthesis. 
Importantly, one of the most striking phenotypes of TRF1-FokI expression was a rapid 
induction of large clusters of telomeres that are found in varying sizes and numbers in 
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different ALT cell lines. Telomere foci sizes in U2OS cells are smaller than other cell 
lines at baseline, and this allowed us to visualize the formation of large telomere clusters.  
Visualization of telomeres in live cells by expression of mCherry-tagged TRF1-
FokI revealed rapid telomeric clustering events that occurred within 1-2 hours of TRF1-
FokI induction by Shield1 and 4-OHT. Similar clustering events were observed much 
more rarely in TRF1-FokI D450A mutant expressing cells in which no DNA cleavage 
occurs. Telomeres traversed between 1-5um in nuclear distance to merge with a recipient 
telomere. Instead of moving randomly prior to collision with a second telomere, telomere 
foci moved directionally toward the recipient telomere, suggesting that an active process 
could be enforcing the merger of two foci.  
We had noted that the chromatin state at ALT telomeres favors accumulation of 
HR factors instead of NHEJ. RPA normally colocalizes with ALT telomeres, which also 
accumulate recombination-promoting proteins such as BRCA1 while NHEJ-promoting 
53BP1 remains at the periphery of telomere foci. Furthermore, telomere overhangs that 
are substrates for initiation of HR are prominent in ALT cells and are increased with 
TRF1-FokI. Thus, we tested whether Rad51, a recombinase that replaces RPA on ssDNA 
overhangs and is critical for homology search and D-loop formation, is required for ALT 
telomere movement. Clustering events and telomere movement were reduced upon 
knockdown of Rad51 by siRNA. Strikingly, GFP-Rad51 filaments could be directly 
visualized between merging telomeres, suggesting that Rad51-ssDNA nucleoprotein 
filament could directly bridge two recombining telomeres in order to facilitate their 
juxtaposition and synapsis.  
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The fact that ALT telomeres traverse several microns within the nucleus to merge 
with another telomere suggests that these recombination events are occurring between 
non-sister telomeres. This is a unique situation since the vast majority of HR reactions in 
somatic cells occur between homologous sequences on sister chromatids. On the other 
hand, a situation in which interchromosomal recombination preferentially occurs is 
during meiotic recombination. Crossover recombination occurs upon programmed DSB 
generation and juxtaposition of homologous chromosomes that are microns away in the 
nucleus. Interestingly, meiotic recombination requires a critical factor called 
Homologous-Pairing 2 (Hop2), which functions together with Mnd1 and the meiotic 
recombinase DMC1 to complete chromosome pairing (Leu et al., 1998; Pezza et al., 
2007). Hop2 and Mnd1 were broadly expressed in all cancer cell lines tested, but its 
expression was limited in mortal fibroblast cell lines. Importantly, knockdown of Hop2 
and Mnd1 reduced ALT telomere clustering and movement following TRF1-FokI 
expression. Furthermore, Knockdown of these proteins resulted in disruption of ALT 
activity by reducing APB formation and telomere exchanges in ALT cells even in the 
absence of TRF1-FokI.  
These data show that ALT telomere recombination is intimately linked to the 
homologous recombination machinery and that a DSB response initiates a homology 
search requiring Rad51 and Hop2-Mnd1. A model for ALT could be proposed based on 
these findings: DSB responses at ALT telomeres triggers recruitment of HR factors that 
carry out a search for a homologous substrate, followed by synapsis, D-loop formation 
and DNA synthesis to complete the repair process. Questions remain as to how the HR 
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factor recruitment process is regulated, and how DNA synthesis proceeds following D-
loop formation. 
RPA-coated single stranded DNA is a substrate readily recognized by ATR 
kinase, which signals downstream to a number of different substrates such as Chk1. It is 
reasonable to hypothesize that RPA-coated single stranded telomeres, which are abundant 
in ALT cells, could activate ATR in order to trigger the recombination pathway. During 
normal recombination, RPA-coated single stranded DNA that becomes exposed recruits 
ATR to initiate a HR-dependent repair pathway that restores the replication fork. A 
similar process could take place during periods of replication stress at ALT telomeres 
occurring in the absence of ATRX (Clynes et al., 2015).   
Inhibition of ATR or Chk1 with small molecule inhibitors resulted in a striking 
reduction of Rad51 and Hop2 localization to ALT telomeres within 4 hours of treatment. 
On the other hand, recruitment of RPA to telomeres did not decrease significantly upon 
ATRi or Chk1i, which is consistent with the expectation that inhibition of ATR would 
not affect the nature of the substrate that it recognizes. We hypothesized that the 
reduction in Rad51 and Hop2 could be directly due to the loss of their recruitment by 
ATR and Chk1, or indirectly due to the effect of ATRi and Chk1i on ALT cells. Since a 
prominent effect of ATRi and Chk1i is fragmentation of the genome from collapsed 
replication forks, we asked whether this phenomenon contributes to the loss of Rad51 and 
Hop2 from ALT telomeres by creating a catastrophic number of DSBs elsewhere in the 
genome that deplete the available pool of HR factors.  
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ATRi and Chk1i caused significant fragmentation of ALT telomeres, as 
evidenced by increased signal upon electrophoresis of free DNA fragments. The DSB 
generation was not specific to telomeres, but instead was global since breaks in Alu 
sequences, interspersed throughout the genome, were more prominent than telomeric 
breaks. These breaks could readily be detected using γH2Ax staining of treated cells. As 
reported previously, the DSB generation from ATRi or Chk1i could be limited using 
roscovitine, a CDK inhibitor, or siMus81. We then analyzed whether elimination of 
DSBs during ATRi or Chk1i could rescue Rad51 and Hop2 loss from telomeres. Upon 
treatment with roscovitine or knockdown of Mus81, Rad51 and Hop2 localization was 
partially rescued even though roscovitine almost completely limited DSB and γH2Ax 
generation. These results indicate that while genome-wide breaks following ATRi and 
Chk1i is a prominent feature that leads to cell death in treated cells, they do not wholly 
account for the loss of Rad51 and Hop2 from ALT telomeres. Further experiments are 
needed in order to understand potential mechanisms of ATR and Chk1-mediated 
recruitment of HR factors in ALT.  
In sum, these data are consistent with a DSB-initiated HR-driven mechanism for 
ALT telomere recombination. However, several aspects of the model still remain unclear. 
How does the terminal process of DNA synthesis occur and which DNA polymerases are 
critical? Are there alternative or co-existing pathways for recombination in ALT?  
A prediction from the proposed model is that ALT recombination events should 
culminate in synthesis of new DNA. In mammalian cells, there are 15 characterized DNA 
polymerases that could fulfill this role. A minority of these polymerases carries out 
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normal replication, while the majority performs various forms of DNA repair. Although 
direct evidence of DNA synthesis by these polymerases during repair has been lacking 
due to a lack of an appropriate mammalian system in which to study DNA synthesis, the 
polymerases that have been implicated in HR or NHEJ include Polβ, Pol ζ, Pol η, Pol θ, 
Pol λ and µ. Interestingly, Pol β was required for synapsis during meiosis, functioning at 
an early step in the processing of meiotic DSBs (Kidane et al., 2010). Pol η deficiency 
results in reduced gene conversion events that occur as a result of HR in chicken DT40 
cells. Additionally, Pol η can perform repair synthesis in vitro to extend the end of the 3’ 
overhang serving as a primer, resulting in second-end capture by Rad52, which is a 
critical step in HR repair reactions involving homology on both ends of the broken strand 
(McIlwraith and West, 2008).  
For ALT telomere synthesis, the putative substrates undergoing recombination 
suggest a similar but distinct type of reaction known as break-induced replication (BIR) 
may occur. While a DSB within the body of the chromosome contains two broken ends 
that need to be repaired, a break at a telomere is a one-ended starting substrate. BIR has 
been most extensively studied in eukaryotes in the budding yeast Saccharomyces 
cerevisiae. During BIR, the initial steps of 3’ ssDNA overhang generation and invasion 
into a region of homology seem to be shared with gene conversion events that occur with 
homology on both ends of the break. However, upon formation of the D-loop, conversion 
to a replication fork-like structure occurs involving leading- and lagging-strand synthesis.  
In yeast, the requirements for replication at this stage are distinct from those of normal S-
phase replication where Pol ε performs leading strand copying while Pol δ copies the 
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lagging strand. Pol32, a component of the Pol δ complex, along with Pol α-Primase 
complex is required for yeast BIR while Pol ε is dispensable for the initial steps of 
synthesis (Lydeard et al., 2007). The mammalian homolog of Pol32 is PolD3, which was 
recently implicated in allowing survival of cells undergoing replication stress upon cyclin 
E overexpression by a BIR-like mechanism (Costantino et al., 2014).  These data suggest 
that the mammalian Pol α, δ and ε complexes are prime candidates for interrogation in 
ALT telomere synthesis which potentially proceeds by BIR as it does in yeast 
telomerase-null survivors (McEachern and Haber, 2006). We have preliminary data using 
TRF1-FokI as a system to probe for newly synthesized DNA at the telomeres. These 
assays should prove useful for understanding the requirements of mammalian DNA 
polymerases for ALT telomere recombination and synthesis.  
A second interesting question that arises from comparison to ALT in yeast is 
whether different mechanisms of ALT recombination could exist. In S. cerevisiae, two 
pathways allow “survivors” to form in the absence of telomerase, both of which require 
Rad52 but only one of which requires Rad51 (Louis et al., 1994; Lundblad and 
Blackburn, 1993; Teng and Zakian, 1999). The first pathway (Type I) is characteristic for 
amplification of subtelomeric Y’ elements along with telomeric repeats, and is dependent 
on Rad51 along with Rad52 and Rad54 (Le et al., 1999; Teng and Zakian, 1999). The 
second pathway (Type II) is notable for long and heterogeneous amplifications involving 
only telomeric repeats, and does not require Rad51 but relies on Rad52, the MRX 
complex and Rad59 (Lundblad and Blackburn, 1993).  
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We have observed that knockdown of Rad51 and Hop2 proteins resulted in ALT 
activity decreases of about 50% across the different assays that were employed including 
APB formation and telomere exchanges. These observations leave open the possibility 
that complementary mechanisms could replace the functions of Rad51in mammalian 
cells. This idea is supported by the observation that yeast BIR can also proceed in Rad51-
dependent and –independent manners (Ira and Haber, 2002; Malkova et al., 2001; Signon 
et al., 2001). A prediction of this model would be that concurrent inhibition of 
complementary pathways on which human ALT cells depend would be more effective in 
reducing ALT activity and inducing cell death. The initial candidates to test in this 
context are human Rad52, the Mre11-Rad50-Nbs1 (MRN) complex, BLM and WRN 
helicases and ATR (Cohen and Sinclair, 2001; Huang et al., 2001; Johnson et al., 2001; 
Signon et al., 2001; Tsai et al., 2002).  
Understanding the mechanisms in play during ALT telomere recombination has 
become an exciting field that provides a system for interrogating poorly characterized 
repair pathways in mammalian cells and offers an opportunity to develop rational 
strategies for targeting ALT-positive tumors. I hope that the work presented in this thesis 
will be useful for subsequent studies of ALT telomeres and homologous recombination.  
 
 
 
 
 
 
 
54 
Figures 
Figure 1 
 
 
 
 
 
 
55 
Figure 1. TRF1-FokI DSBs Promote Telomeric Clustering in ALT Cells  
(A) Schematic of telomere-specific DSB induction by the TRF1-FokI fusion protein.  
(B) Comparison of DSB responses in U2OS cells between TRF1-FokI expression and 
escalating doses of IR. Immunoblot (IB) was performed at 30 minutes following 
irradiation. Mock indicates mock viral transduction; D450A and WT indicate nuclease 
inactive and wild type TRF1-FokI, respectively.  
(C) Representative immuno-FISH images of TRF1-FokI (Flag) WT or D450A 
colocalized with telomeres (PNA) in ALT positive and negative cells.  
(D) Average telomere foci size per nucleus after TRF1-FokI expression was calculated 
using ImageJ. Mean ± standard error of the mean (s.e.m.) for  >50 cells in n = 3. * 
p<0.05, n.s. p>0.05.  
(E) FISH was performed in cells expressing TRF1-FokI WT or D450A using a 
combination of chromosome-specific subtelomeric (subtel) probes and PNA. Percentages 
of colocalized subtel-PNA foci that contained one, two or three subtelomeric signals were 
quantified from >100 cells in n =2.   
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Figure 2 
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Figure 2. TRF1-FokI Induced Clustering Occurs Specifically in ALT Cells 
(A) Cells that were mock treated or transduced with TRF1-FokI WT or D450A virus 
were incubated with BrdU for 1 hour then analyzed by flow cytometry.  
(B) Representative immunofluorescence images for two additional ALT and telomerase 
positive cell lines after expression of TRF1-FokI WT or nuclease inactive D450A mutant. 
(C) Fraction of PNA signal positive telomeres per total ends for each metaphase was 
quantified after TRF1-FokI expression. Mean of >40 metaphases were calculated from 2 
independent experiments. 
(D) GFP-LacI and TRF1-FokI were co-expressed in U2OS reporter cell line with LacO 
repeat sites integrated into a subtelomeric genomic locus at 1p36. 
(E) FISH was performed in cells expressing TRF1-FokI WT or D450A, using the 
indicated chromosome-specific subtelomeric probes and PNA. Percentages indicate 
percentage of subtelomeric signals that are adjacent to a telomeric signal, quantified from 
>100 cells in two independent experiments.  
  
 
 
58 
Figure 3 
 
 
 
 
59 
Figure 3. TRF1-FokI DSBs Promote ALT Activity  
(A) Representative PNA/anti-PML immuno-FISH images of cells expressing TRF1-FokI 
WT or nuclease inactive D450A mutant.  
 (B) Number of PML-PNA colocalizations (APBs) per nucleus was quantified in cells 
expressing TRF1-FokI WT or D450A. Mean of >100 cells from three replicate 
experiments. *** p < 0.005, n.s. p > 0.05. 
(C) Representative images of edU positive TRF1-FokI foci in VA13 cells.  
(D) Fraction of nuclei with ≥ 3 TRF1-FokI telomere foci colocalizing with edU foci in 
non-S-phase cells was quantified after expression of TRF1-FokI as indicated. Mean ± 
s.e.m., >50 cells in n = 3. * p<0.05.  
(E) Digested genomic DNA from cells expressing TRF1-FokI was resolved by pulsed-
field gel electrophoresis (PFGE) and probed for total telomeric DNA. 
(F) Digested genomic DNA from U2OS cells expressing TRF1-FokI WT or D450A were 
treated with Bal31 nuclease for the indicated durations, resolved by PFGE and probed for 
total telomeric DNA.  
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Figure 4 
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Figure 4. TRF1-FokI DSBs Promote ALT Activity 
(A) The percentage of cells with ≥ 3 telomere foci colocalizing with PML was quantified 
in the indicated cell lines following TRF1-FokI expression (Mean ± s.e.m., >50 cells in n 
= 3. * p<0.05).  
(B-C) U2OS cells were transfected with mCherry-TRF1-FokI and induced with Shield1 
and 4-OHT for the indicated durations, and c-circle assay was performed using the 
indicated amounts of genomic DNA. Mean ± s.e.m., n=4. 
(D-E) U2OS cells were transduced with mock, TRF1-FokI D450A or WT virus for 24 
hours and c-circle assay was performed using the indicated amounts of genomic DNA. 
Mean ± s.e.m., n=2.  
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Figure 5 
 
 
63 
Figure 5. ALT Telomere DSBs Rapidly Associate by Long Range, Directional 
Movement  
(A) Schematic of time-lapse imaging of telomeres in cells expressing TRF1-FokI. mC, 
mCherry; ER, modified estrogen receptor; DD, destabilization domain.  
(B) Representative 1-hour traces of mCherryTRF1-FokI D450A or WT foci in U2OS 
nuclei. White box indicates region shown in (E).  
(C) Quantification of telomere-telomere clustering where merged foci remain 
unseparated in 3 or more frames. In red, mean ± s.e.m. Each datapoint represents tracked 
nuclei from two independent experiments. *** p<0.0005. TRF1only represents 
mCherryTRF1 protein without C-terminal FokI.  
(D) Mean squared displacement (MSD) analysis of telomere movement in U2OS cells 
expressing mCherryTRF1-FokI D450A or WT. Δt, time interval. Error bars, weighted 
s.e.m. and n = >700 tracks in two independent experiments. Fit was determined by a 
diffusion model, 𝑀𝑆𝐷 =   Γ𝑡!, where α is the time dependence coefficient. α WT = 0.8 and 
α D450A = 0.7. 
(E) Expanded images of a tracing from (B) highlighting diffusive movement followed by 
directed movement toward another telomere. * and bar denotes displacement measured in 
(F). Yellow lines indicate the path traveled by the particle during the previous 10 frames.  
(F) Quantification of telomere displacement during directed movement (mean ± s.e.m of 
tracks from 2 independent experiments; n.s. p>0.05). Directed phase was defined by 
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consecutive motion toward the recipient telomere over 3 or more frames until the merge 
event. 
(G) MSD analysis of clustering telomeres in U2OS cells expressing TRF1-FokI WT (see 
text). ΔT=18 represents the point of merge into a recipient telomere. n = 157 tracks from 
2 independent experiments. Error bars, weighted s.e.m. 
(H) Data from (G) is displayed on a log-log plot. Time dependence coefficient, α, for two 
phases of movement is indicated.  
(I) MSD analysis of mobility before and after a merge event. Δt=0 represents the point of 
merge. Error bars, weighted s.e.m. and n = 46 tracks from two independent experiments.  
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Figure 6 
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Figure 6. Damage-dependent Chromatin Movement in ALT is Telomere Specific 
(A) Schematic of U2OS reporter cell line containing integrated LacO transgene proximal 
to the chromosome 1p telomere.   
(B) Montage of live-cell images captured after induction of mCherry-LacI-FokI DSBs in 
the reporter cell line.  
 (C) Montage of live cell images in a representative U2OS cell expressing GFP-53BP1. 
Cells were treated with 2Gy IR and visualized after one hour. Arrowheads follow three 
GFP-53BP1 spots over the course of the experiment.  
(D) mCherry-TRF1-FokI and GFP LacI were co-expressed in the U2OS reporter cell line 
and visualized with live cell imaging. 
(E) Time-dependent diffusion coefficient D(t) = MSD/Δt is plotted on a log-log scale for 
telomeres in cells expressing TRF1-FokI WT or D450A.  
(F) Telomere clustering events in U2OS cells co-expressing mCherry-TRF1-FokI and 
GFP-PML were analyzed with respect to an associated GFP-PML signal.  
(G) Live cell images of VA13 cells co-expressing mCherry-TRF1only and GFP-53BP1 
were analyzed for telomeres with or without colocalized 53BP1 signal.  
(H) Montage of a representative clustering event in experiment in (G).  
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Figure 7 
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Figure 7. Homologous Recombination Predominates at ALT Telomere DSBs  
(A) Representative immunofluorescence images of RPA2 and mCherry-TRF1-FokI WT 
in HeLa1.3 and VA13 cells.  
(B) Quantification of RPA-telomere colocalization in ALT cell lines (U2OS and VA13) 
and a telomerase positive cell line (HeLa1.3). 
(C) Telomeric DNA from U2OS and HeLa1.3 cells expressing TRF1-FokI D450A or WT 
was resolved by PFGE, and probed with p32 labeled oligos hybridizing to the G-rich 
single-stranded telomeres under native conditions. The gel was denatured and probed 
again for total telomeric signal. 
(D) Representative immunofluorescence images of Rad51, BRCA1 and 53BP1 and 
mCherryTRF1-FokI WT and D450A positive telomeres in U2OS cells.  
(E) Colocalization of Rad51 and BRCA1 to mCherryTRF1-FokI WT and D450A positive 
telomeres in ALT positive and negative cells. Tel, direct overlying colocalization to 
telomeres; Mean + s.e.m., n=2.  
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Figure 8 
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Figure 8. Increased Single-stranded Telomeric Signal is Largely from Telomeric 
Overhangs  
(A) Digested genomic DNA from U2OS cells expressing TRF1FokI D450A or WT were 
treated with Exonuclease I prior to resolution by pulsed-field gel electrophoresis and 
hybridization under native and denatured conditions.  
(B) Representative triple stained confocal microscopic images of native telomeres in 
ALT nuclei that accumulate 53BP1 and BRCA1. 
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Figure 9 
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Figure 9. Rad51 Promotes Diffusive and Directed ALT Telomere Movement 
(A) Quantification of TRF1-FokI induced telomere clustering at 72 hours following 
transfection of siRNA targeted to the indicated genes. Mean ± s.e.m., n=3. p values refer 
to tests between siLuciferase and indicated siRNA. ** p<0.005, n.s., p>0.05. See 
Experimental Procedures for analysis of clustering.  
(B) Top panels, FISH image of a VA13 cell expressing GFP-Rad51, hybridized with 
telomeric PNA probe. Last panel shows an expanded area demarcated by the white box. 
Bottom panels, fluorescence image of a VA13 cell co-expressing mCherry-TRF1-FokI 
and GFP-Rad51. 
(C) Representative montage of a live-cell telomere clustering event in a VA13 cell 
expressing mCherry-TRF1-FokI and GFP-Rad51.  
(D) MSD analysis of telomere movement after Rad51 knockdown in U2OS cells. 
Nuclease inactive D450A is shown for reference. Fit determined by a diffusion model, 𝑀𝑆𝐷 =   Γ𝑡!. Error bars, weighted s.e.m. and n > 450 tracks from two independent 
experiments. 
(E) Number of telomere clustering events that occur per nucleus following directed 
movement is quantified after Rad51 knockdown in U2OS cells. Mean ± s.e.m. from two 
independent experiments. *** p<0.0005. 
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Figure 10 
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Figure 10. Rad51 Guides ALT Telomere Movement and Clustering 
(A) Western blotting was performed in U2OS cells at 72h after knockdown of the 
indicated genes by siRNA.  
(B) Live cell imaging was performed in VA13 cells co-expressing mCherry-TRF1FokI 
and GFP-Rad51. Cells that contained at least one GFP-Rad51 filament in between 
telomeres were analyzed for percentages of clustering telomeres that displayed the 
following characteristics: (1) colocalization with GFP-Rad51 foci, or (2) connected by a 
GFP-Rad51 filament. n = 35 total clustering events analyzed from 4 independent 
experiments.  
(C) U2OS cells expressing TRF1-FokI WT were transfected with GFP-Rad51 WT or 
K133R mutant. Average PNA telomeric foci size per nucleus was calculated from >100 
cells from three experiments. Mean ± s.e.m., *** p<0.0005.  
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Figure 11 
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Figure 11. Hop2-Mnd1 Regulate Telomere Clustering and Recombination in ALT 
(A) Western blotting was performed in the indicated cell lines using an antibody that 
recognizes the endogenous Hop2 protein.  
(B) Telomere clustering in U2OS cells expressing TRF1-FokI was quantified as in (5A) 
after Hop2-Mnd1 knockdown. Mean ± s.e.m., n = 3. ** p<0.005, *** p<0.0005. 
(C-D) Live-cell analysis of telomere movement in U2OS cells expressing mCherryTRF1-
FokI WT was used to quantify telomere clustering after knockdown with the indicated 
siRNAs. D450A is shown for reference. Fit determined by 𝑀𝑆𝐷 =   Γ𝑡!. Error bars, 
weighted s.e.m. and n > 550 tracks from two independent experiments. ** p<0.005, *** 
p<0.0005. 
(E) Representative images of telomere colocalization with PML foci in VA13 cells after 
control or Hop2 knockdown.   
(F) Spontaneous APB formation was assessed in VA13 cells after serial knockdown of 
Hop2 or Mnd1 (Extended Experimental Procedures). Mean from >100 cells from 3 
experiments.  
(G) Spontaneous APB formation was assessed following Hop2 siRNA targeting the 3’ 
UTR region in parental VA13 cells and  in VA13 cells stably expressing Hop2 cDNA. 
Mean from >100 cells from 3 experiments.  
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(H) Representative examples of telomere exchanges from CO-FISH are shown for cells 
with control or Hop2 knockdown (siRNA #1). The arrowhead reveals a T-SCE. Full 
images shown in Figure S7C.  
(I) Quantification of total number of exchanges from CO-FISH assay after Control, Hop2 
or Mnd1 knockdown. >50 metaphases in two independent experiments.  
 
 
78 
Figure 12 
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Figure 12. Hop2-Mnd1 Regulates Telomere Clustering and Recombination in ALT.  
(A) Western blotting was performed in the indicated ALT cell lines using an antibody 
that recognizes endogenous Hop2 protein.  
(B) Quantitative RT-PCR was performed after transfection of the indicated siRNA in 
U2OS cells. Mean ± s.e.m., n=2.  
(C) Western blotting was performed using the anti-Hop2 antibody after transfection of 
the indicated siRNA in U2OS cells. *, nonspecific band seen in longer exposures. White 
line is shown to indicate irrelevant lanes between siCTL and siHop2 were removed.  
(D) Live-cell analysis of telomere movement in U2OS cells expressing mCherryTRF1-
FokI WT was used to quantify telomere clustering after knockdown with the indicated 
siRNAs. D450A is shown for reference. Nonlinear fit determined by a single exponential 
diffusion model, 𝑀𝑆𝐷 =   Γ𝑡!. Error bars, weighted s.e.m. and n > 550 tracks from two 
independent experiments. 
(E) IF was performed in VA13 cells with antibodies to the Flag epitope and to 
endogenous Hop2 protein as indicated at 72 hours after indicated siRNAs and 24 hours 
after expression of Flag-TRF1FokI.  
(F) Endogenous Hop2 localization to telomeres was quantified in VA13 and HeLa 1.3 
cells with or without TRF1-FokI expression.  
(G) Schematic of Hop2 protein, highlighting its domain structure and the M110 residue 
within the Leucine Zipper (LZ) domain. 
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(H) GFP-Hop2 localization proximal to TRF1-FokI was assessed in U2OS cells. The 
Leucine Zipper domain mutant, M110P abolished GFP-Hop2 colocalization with TRF1-
FokI. 
(I) Flag-TRF1FokI WT was expressed in VA13 cells at 48 hours after transfection with 
the indicated siRNA. Immunofluorescence was performed with anti-Flag and anti-Rad51. 
Mean ± s.e.m, n = 2; n.s., p>0.05. 
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Figure 13 
 
 
Figure 13. Model for a Specialized Homology Search Mechanism that drives ALT 
Telomere Recombination 
A specialized homology searching mechanism is required for synapsis between distant 
telomeres. Extensive end resection at ALT telomeres facilitates a Rad51 dependent 
homology search. Homology capture followed by synapsis and congression of 
homologously paired non-sister telomeres would be responsible for directional telomere 
movement. This ALT telomere recombination mechanism relies in part on Rad51 and 
Hop2-Mnd1 to promote synapsis between non-sister telomeres. 
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Figure 14 
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Figure 14. Hop2-Mnd1 Regulates Telomere Clustering and Recombination in ALT.  
(A) Spontaneous APB formation was assessed in ALT cell lines with Hop2-Mnd1 
depletion. Positive cells exhibited ≥ 3 colocalized foci. siH+M indicates cotransfection of 
siHop2#1 and Mnd1#1. Mean ± s.e.m., n = 3. * p<0.05 
(B) Western blotting was performed with antibodies to PML or Hop2 in VA13 cells 72 
hours after transfection of indicated siRNAs.  
(C) Representative images of CO-FISH experiments after knockdown of Hop2. Examples 
of telomere exchanges are highlighted with white arrowheads.  
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Figure 15 
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Figure 15. Hop2 localization to telomeres is disrupted upon ATR or Chk1 
inhibition. 
(A) Representative PNA/Hop2 immuno-FISH images of VA13 cells treated with or 
without ATR inhibitor (VE-821) for 24h prior to fixation. TRF1-FokI virus was added 
24h prior to fixation. 
(B) Quantification of Hop2-PNA colocalization events in VA13 cells treated with VE-
821 for the indicated durations prior to fixation. TRF1-FokI virus was added 24h prior to 
fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. 
(C) Representative PNA/Hop2 immuno-FISH images of VA13 cells treated with or 
without Chk1 inhibitor (LY-2603618) for 24h prior to fixation. TRF1-FokI virus was 
added 24h prior to fixation. 
(D) Quantification of Hop2-PNA colocalization events in VA13 cells treated with LY-
2603618 for the indicated durations prior to fixation. TRF1-FokI virus was added 24h 
prior to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. 
(E) Quantification of Hop2-PNA colocalization in VA13 and GM847 ALT cells treated 
with or without VE-821 for 24h prior to fixation. TRF1-FokI virus was added 24h prior 
to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. * p<0.05 
(F) Quantification of Hop2-PNA colocalization in VA13 cells treated with or without 
Chk1 inhibitor (CHIR-124) for 24h prior to fixation. TRF1-FokI virus was added 24h 
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prior to fixation. Mean ± standard error of the mean (s.e.m.) for >50 cells in n = 2. ** 
p<0.005 
(G) Quantification of Hop2-PNA colocalization in VA13 cells transfected with the 
indicated siRNAs. TRF1-FokI virus was added 24h prior to fixation. Mean ± standard 
error of the mean (s.e.m.) for >50 cells in n = 3. *** p<0.0005 
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Figure 16 
 
 
 
88 
Figure 16. ATR and Chk1 inhibition reduces Rad51, but not RPA, localization to 
ALT telomeres.  
(A) Quantification of RPA/PNA colocalization events in VA13 cells treated with or 
without VE-821 for 24h. Mean ± standard error of the mean (s.e.m.) for  >50 cells in n = 
3. n.s. p>0.05. 
(B) Representative RPA/PNA immuno-FISH images of VA13 cells treated with or 
without VE-821 for 24h.  
(C) Quantification of Rad51/PNA colocalization events in VA13 cells treated with or 
without VE-821 for 24h. Mean ± standard error of the mean (s.e.m.) for  >50 cells in n = 
3. n.s. p>0.05. 
(D) Representative Rad51/PNA immuno-FISH images of VA13 cells treated with or 
without VE-821 for 24h.  
(E) Quantification of RPA/PNA colocalization events in U2OS cells treated with or 
without VE-821 for 24h. TRF1-FokI virus was added 24h prior to fixation. 
(F) Quantification of Rad51/PNA colocalization events in U2OS cells treated with or 
without VE-821 for 24h. TRF1-FokI virus was added 24h prior to fixation. 
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Figure 17
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Figure 17. Genome fragmentation occurs following ATR or Chk1 inhibition.  
(A) Representative PNA FISH images of VA13 cells treated with ATRi (VE-821) or 
Chk1i (LY-2603618).  
(B) C-circle assay was performed on genomic DNA isolated from VA13 cells treated 
with the indicated drugs.  
(C) VA13 cells treated with the indicated durations of VE-821 were embedded in agarose 
plugs and electrophoresed to visualize fragmented DNA with the indicated probes (Tel, 
6xCCCTAA; Alu, alu-repeat specific). 
(D)  VA13 cells treated with the indicated durations of CHIR-124 were embedded in 
agarose plugs and electrophoresed to visualize fragmented DNA with the indicated 
probes (Tel, 6xCCCTAA; Alu, alu-repeat specific). 
(E) Quantification of lane intensity was performed using ImageJ. Values were normalized 
to the intensity of 0h time point.  
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Figure 18 
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Figure 18. γH2Ax is increased following ATR or Chk1 inhibition in LM216ALT and 
LM216TEL cells.  
(A) LM216ALT and LM216TEL cells were incubated with VE-821 for the indicated 
durations, stained for γH2Ax and PI, and analyzed by flow cytometry.  
(B) LM216ALT and LM216TEL cells were incubated with CHIR-124 for the indicated 
durations, stained for γH2Ax and PI, and analyzed by flow cytometry. 
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Figure 19
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Figure 19. Roscovitine and Mus81 knockdown rescues the effects of ATRi and 
Chk1i. 
(A) VA13 cells treated with the indicated drugs for 24h were embedded in agarose plugs 
and electrophoresed to visualize fragmented DNA with the indicated probes (Tel, 
6xCCCTAA; Alu, alu-repeat specific). 
(B) VA13 cells treated with the indicated drugs for 24h were stained for γH2Ax and PI, 
and analyzed by flow cytometry.  
(C-D) Rad51/PNA and Hop2/PNA colocalization events were quantified in VA13 cells 
treated with the indicated drugs for 24h. For Hop2 analysis, TRF1-FokI virus was added 
24h prior to fixation. LY260 represents LY-2603618. 
(E-F) Rad51/PNA and Hop2/PNA colocalization events were quantified in VA13 cells 
transfected with control or Mus81 siRNA and treated with the indicated drugs for 24h. 
For Hop2 analysis, TRF1-FokI virus was added 24h prior to fixation.  LY260 represents 
LY-2603618. 
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Figure 20 
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Figure 20. CRISPR-Cas9 mediated deletion of Hop2 suppress ALT phenotypes 
(A) Western blotting was performed in VA13 cells selected for expression of the 
indicated guide RNAs (sgHop2 a-e).  
(B) Representative PNA/Hop2 immuno-FISH images of VA13 parental cells and VA13 
cells expressing sgHop2-b.  
(C) Representative PNA/PML immuno-FISH images of VA13 parental cells and VA13 
cells expressing sgHop2-b.  
(D) Number of PML-PNA colocalizations (APBs) per nucleus was quantified in VA13 
parental cells and VA13 sgHop2-b cells.  *** p < 0.005 
(E) Average PNA foci size per nucleus was quantified in VA13 parental cells and VA13 
sgHop2-b cells. * p < 0.05 
(F) After a BrdU pulse of 2h, % of cells outside of S phase that contained >2 BrdU-PNA 
colocalizations was quantified in VA13 parental cells and VA13 sgHop2-b cells. * p < 
0.05 
(G) Total number of signal exchanges from CO-FISH assay was quantified in VA13 
parental cells and VA13 sgHop2-b cells. ** p <0.005 
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Movies 
Movie 1. Live cell imaging of telomeres after DSB induction demonstrates 
movement and clustering. Representative U2OS nucleus expressing mCherry-ER-DD-
TRF1-FokIWT, Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then 
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2 
minutes, and each frame represents the stack as a projection onto a single plane. mCherry 
signals appear in white, while the colored lines track the path traveled by the mCherry 
focus.   
Movie 2. Live cell imaging of telomeres in the absence of DSBs. Representative U2OS 
nucleus expressing the nuclease-inactive mCherry-ER-DD-TRF1-FokID450A. Cells 
were induced for 60 minutes with 4-OHT and Shield1 ligand, then imaged for the 
following 60 minutes. Z stacks of mCherry signals were acquired every 2 minutes, and 
each frame represents the stack as a projection onto a single plane. mCherry signals 
appear in white, while the colored lines track the path traveled by the mCherry focus.   
Movie 3. Example of spontaneous telomere clustering. Representative U2OS cell 
nucleus with induction of the mCherry-ER-DD-TRF1only protein by 4-OHT and Shield1 
ligand. Images were acquired as Z stacks every 2 minutes, and each frame represents the 
stack as a projection onto a single plane. White box highlights a spontaneous telomere 
association event.  
Movie 4. Live cell imaging of mCherry-TRF1FokI foci and interconnecting GFP-
Rad51 filaments in a VA13 cell. An example of a telomere clustering event with an 
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interconnecting GFP-Rad51 filament. Images were acquired as Z stacks every 4 minutes, 
and each frame represents the stack as a projection onto a single plane. 
Movie 5. Live cell imaging of telomeres in U2OS transfected with control siRNA. 
mCherry-ER-DD-TRF1-FokI WT was transfected at 48h following transfection with 
control siRNA and imaging performed 16 hours later. Cells were induced for 60 minutes 
with 4-OHT and Shield1 ligand, then imaged for the following 60 minutes. Z stacks of 
mCherry signals were acquired every 2 minutes, and each frame represents the stack as a 
projection onto a single plane.  
Movie 6. Live cell imaging of telomeres in U2OS transfected with siRNA targeted to 
Rad51 demonstrates reduced movement. mCherry-ER-DD-TRF1-FokI WT was 
transfected at 48h following transfection with siRad51 #2, and imaging performed 16 
hours later. Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then 
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2 
minutes, and each frame represents the stack as a projection onto a single plane.  
Movie 7. Live cell imaging of telomeres in U2OS transfected with siRNA targeted to 
Hop2 demonstrates reduced movement. mCherry-ER-DD-TRF1-FokI WT was 
transfected at 48h following transfection with siHop2 #2, and imaging performed 16 
hours later. Cells were induced for 60 minutes with 4-OHT and Shield1 ligand, then 
imaged for the following 60 minutes. Z stacks of mCherry signals were acquired every 2 
minutes, and each frame represents the stack as a projection onto a single plane.  
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